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resumo 
 
 
A epigenética pode ser definida pela ocorrência de modificações no genoma, 
que são herdadas durante a divisão celular, não havendo no entanto 
modificações directas na sequência do DNA. Estas modificações genómicas 
são apoiadas em três grandes mecanismos epigenéticos: metilação do DNA, 
modificação de histonas e pequenos RNAs. Estas diferentes marcas 
epigenéticas podem ter como função regular a transcrição genética, pois 
quando existe algum tipo de alteração nestes processos, pode desencadear-se 
em diversas patologias como o cancro. 
Assim, o objectivo principal deste trabalho é estudar os sinais epigenéticos no 
genoma humano, ou seja, observar se existe dependência entre o contexto e a 
ocorrência da marcação epigenómica. Para esse efeito foram utilizados os 
epigenomas das histonas disponíveis na base de dados do NIH Roadmap 
Epigenomics Mapping Consortium que contêm vários tipos de células e vários 
tipos de tecidos. No presente estudo são empregues diferentes metodologias 
estatísticas, nomeadamente testes estatísticos, medidas do tamanho do efeito, 
análise de resíduos e classificação hierárquica. Com esta análise, comparam-
se contextos genómicos da marcação epigenética entre cromossomas e entre 
epigenomas. Complementando a análise com um cenário de controlo, sem 
marcação e factorizando pelo teor de CG. 
Foi possível identificar uma dependência entre o contexto e a ocorrência de 
marcação epigenética, sendo possível identificar contextos genómicos 
específicos para as modificações das histonas.  
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abstract 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Epigenetics can be defined as changes in the genome that are inherited during 
cell division, however without direct modify the DNA sequence. These genomic 
changes are supported by three major epigenetic mechanisms: DNA 
methylation, histone modification and small RNAs. Different epigenetic marks 
function by regulating gene transcription, because when these processes are 
altered, this triggers various diseases such as cancer. 
Thus, one main objective was to study the epigenetics signals in the human 
genome, meaning, whether there is dependence observed between the context 
and the occurrence of epigenomic marking. For this purpose we used  histone 
epigenomes available in the NIH Roadmap Epigenomics Mapping Consortium 
database that contains various types of cells and various types of tissues. The 
present study employed different statistical methodologies, namely, statistical 
tests, effect size measures, residue analysis and hierarchical classification. 
With this analysis, we compared genomic contexts of epigenetic marking 
among chromosomes and among epigenomes. Complementing the analysis 
with a control scenario, without marking and factoring the CG content. 
As a result of this study, it was possible to identify one dependency between 
the context and the occurrence of epigenetic marking and we were able to 
identify specific genomic contexts in histone modifications. 
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1. Introduction 
Genetics has been one of the most developed areas of research, particularly after the 
discovery of the structure of deoxyribonucleic acid (DNA). This area investigates the 
constitution of genes, processes of inheritance, what physical disorders can be present in 
the genetic map and how DNA controls the structure, function and behavior of cells and 
the way it encodes proteins (1). 
The genetic language is universal, and is mainly contained in DNA. In turn, DNA is 
located within almost all human cells, organized into structures that are designated 
chromosomes. In its composition, DNA has four nitrogenous bases called nucleotides, 
designated by: adenine (A), guanine (G), thymine (T) and cytosine (C). In addition to these 
four nucleotides, the DNA is composed by a lateral chain of orthophosphates (phosphoric 
acid) and deoxyriboses (1). 
 
Figure 1: DNA and RNA structure. The DNA molecule has a structure the double helix. The 
nucleotides are linked through the sugar-phosphate backbone phosphodiester linkages 3'-5. Between 
the two chains, adenine binds to thymine, and guanine with cytosine constituting the double helix 
structure. The RNA is a single-stranded molecule containing A, C, G and uracil (U) instead of thymine. 
Adapted image (2). 
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As can be seen in figure 1, the DNA molecule has a structure of helix double, 
forming a spiral. The nucleotides are linked through the sugar-phosphate backbone by 
phosphodiester linkages 3'-5’ between the two chairs, adenine binds to thymine, guanine 
to cytosine constituting by wear interactions that allows for the double helix structure. 
On the other hand, ribonucleic acid (RNA) acts as an intermediate in protein synthesis, 
acting between DNA and proteins. It is a single-stranded nucleotide polymer, containing 
A, C, G and uracil (U). Furthermore, it has ribose instead of deoxyribose as sugar 
constituent (1).  
The C+G content it is important and is the percentage of nitrogenous bases on a 
DNA molecule that are either guanine or cytosine and the C+G pair between to 
complementary DNA chains is bound by three hydrogen bonds, so DNA with high C+G 
content is more stable than DNA with low C+G content (1).  
This content is associated with the denaturation of DNA, which is the process by 
which double stranded DNA unwinds and separates into two single strands, through the 
breaking of hydrogen bonds between complementary bases. With the increase of 
temperature, the breaking of bonds increases, meaning that the temperature increase acts 
as a denaturing agent. This melting temperature depends directly on the guanine and 
cytosine content of the molecule, because the higher the C+G content is the largest 
numbers of triple bonds have to be broken, requiring a higher temperature for 
denaturation to occur. After denaturation, if the temperature decrease, there is 
hybridization of DNA, i.e. re-established went of hydrogen bonding among the 
complementary bases and return to the double-stranded form (1). 
The DNA can be interpreted as the sequence of four nucleotides A, C, T and G, 
which contain information on hereditary characteristics and are necessary for the 
continuous production of protein and consequent survival of living beings. We can also 
have dinucleotides that are composed of two monomers are united nucleotides; the 
compounds of three nucleotide monomers are known as trinucleotides; and 
tetranucleotides that are composed of four monomers are united nucleotides. 
However, there is a level of gene regulation that does not involve altering DNA 
sequence. This is called epigenetics, and is one of the most promising and intriguing 
areas of genetics. Epigenetics is the science that studies the interaction between gene 
regulation, i.e. how genes are expressed, and its surrounding environment without 
3 
 
involving changes in the DNA sequence level, which may still persist in future 
generations (3–5).  
The cell differentiation is a natural event in every organism, which involves no 
alteration of DNA sequence. However, each cell type has its own gene expression 
pattern. All cells in an organism share the same genome (except B lymphocytes), each 
cell type possesses different kinds of epigenetic signature, and each has a cell-type 
specific epigenome. 
“Epigenetic memory” is a new but distinct term,  that refers to the transmission of a 
gene expression state through multiple cell generations in the absence of initiation signs 
and genetic variation and could be propagated by various epigenetic mechanisms, such 
as, DNA methylation, histone modifications and replacement of histone variants (3–5). 
The inheritance of these epigenetic marks, from mother to daughter cells, is crucial for 
the maintenance of a cell differentiation state. 
In other words, epigenetic has to do with changing the whole genome regulatory 
activity without involving changes in the DNA sequence. This regulatory activity can be 
resumed in the epigenome, which is a kind of map that overlays the map of the genome, 
with epigenetic makes that turn on or off genes, increasing or reducing its activity. 
This can only be studied through genomics, which refers to genetic sequencing and 
analysis of the global genome of an organism. Wherein, the genome is the integer index 
of DNA that is present within a cell of an organism (6,7). Genomics aims to determine 
complete sequences of DNA and draw their genetic trait, in order to help understand its 
functions and dysfunctions, and to study all genes, involving DNA, messenger RNA 
(mRNA), and proteome at both the cell level or tissue level (6,7). 
An important note is that epigenome is not static as the genome, meaning, that the 
epigenome can be dynamic, influenced by environmental factors and extracellular 
stimuli, and change rapidly in response to these factors (6,7). 
As we will see, epigenetics can be regulated by three mechanisms: DNA 
methylation, histone modification and small RNAs. However, in this work, we have 
studied epigenetic signals present in the human genome, focusing mainly on the 
epigenetic regulation related to histone modification. 
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1.1. Histone modifications and chromatin structure  
At the level of chromatin, it exists a mechanism of epigenomic control, since 
nuclear DNA is associated with histones and other proteins in a complex structure 
referred to as chromatin. As can be seen in figure 2, DNA is wrapped around two copies 
of each of the four core histone proteins H3, H4, H2B, and H2A (see example in figure 
3), to form the nucleosome which is the fundamental repeating unit of chromatin. The 
nucleosomes are condensed into higher order structures, which in turn form the 
chromatin (8–10). This will be necessary for efficient packaging of the DNA into the 
nucleus of the cell. However, because when DNA is compacted into this structure, its 
accessibility becomes greatly limited, it serves as a mechanism by which the cell 
protects DNA from external damage but it also regulates DNA mediated processes, such 
as transcription, DNA replication, DNA repair and chromosome segregation (8–10). 
 
 
Figure 2: Structure of chromatin. DNA is wrapped around two copies of each of the four core 
histone proteins H3, H4, H2B, and H2A, to form the nucleosome which is the fundamental 
repeating unit of chromatin. The nucleosomes are condensed into higher order structures, which in 
turn form the chromatin. Adapted image (11,12). 
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Figure 3: Types of histones: H1, H2A, H2B, H3 and H4. The four core histone proteins H3, H4, 
H2B, and H2A, form the nucleosome. Histone H1 binds to DNA at the end of each nucleosome and 
is important for spacing the internucleosomal region.  H1 is also known as H5, the basic structure 
of chromatin consists of 200 pairs of bases of DNA attached to an octamer of histones (H2A, H2B, 
H3 and H4); H2A and H2B have much lower molecular weight than histone H1 and are considered 
rich in lysine; H3 and H4 are rich in arginine.  Two histones from each class (H2A, H2B, H3 and 
H4) aggregate to form a nucleosome, together with DNA. Histone H1 is required for DNA-histone 
complexes to form a fibre, thereby winding the DNA even more effectively. Adapted image (13). 
      
So, these histone proteins can influence chromatin organization and regulate many 
DNA-templated processes, through their chemical modification patterns (acetylation, 
methylation, sumoylation, and ubiquitylation) (8,14). Changes on the histone 
modification status may be associated with active or inactive chromatin. In addition, the 
combinatorial nature of various histone modifications occurring at different times 
during development, and at specific sites within histones, provides additional levels of 
regulation and complexity to the epigenome (9). 
Regarding the structure of each histone, each one is composed of a conserved 
globular histone-fold domain, with extended N and C-terminal tails. The globular 
domains of the histone proteins form the nucleosome core, around which 146 base pairs 
of DNA are wrapped (10). The histone tails serve as the modification site as explain 
abowe (10). 
More recently, the post translational modifications done to histones include lysine 
and arginine methylation, lysine acetylation, serine and threonine phosphorylation, 
monoubiquitylation, sumoylation and proline isomerization, as described in detail in 
annex 1 (8,10). 
How many of these modifications exert some biological effect, and how the 
addition or removal of many of these modifications is regulated is still unclear. These 
modifications may directly affect chromatin structure, such as altering histone-DNA or 
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internucleosomal interactions, whereas others may act indirectly, recruiting or 
preventing the binding of specific proteins to chromatin (8).  Also, in some cases, 
recognition of specific histone modifications by various effector proteins is thought to 
mediate specific biological processes such as gene activation or gene repression (8,15). 
Furthermore, alteration of histone charges by modifications, such as acetylation and 
phosphorylation are thought to induce localized structural changes in chromatin, 
allowing protein factors to access the DNA. Thus, it has been observed that 
misregulation of the addition and/or removal of these modifications, or of the enzymes 
that catalyse them, are implicated in human disease, including various cancers (9). 
In addition, it is important to understand the notation of histone modifications, 
since a wide array of them has been identified and a standardized nomenclature has 
been proposed. The Brno nomenclature (example in figure 4) was created by a 
consortium of European laboratories to standardize notation of histones and histone 
modifications (15).  
 
Figure 4: The Brno nomenclature for histone modifications. The histone protein (H3, H4, H2A, or 
H2B) is indicated first, followed by the amino acid that is modified (ex. “K27” represents lysine 27). 
This is followed by the type of modification that is observed (ex. “me3” represents tri-methylation). 
 
The modification of histone proteins is another possible mechanism of epigenetic 
memory. Histone proteins are subjected to various types of post translational 
modifications, as previously mentioned, and these modifications are associated with 
different cellular functions, such as transcriptional/translational regulation, DNA 
replication/repair and nucleosome compaction. However, the mechanism of replication 
of histone modification after cell division is less understood, and it is not yet clear how 
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the histone modifications, and hence such an epigenetic memory contained in a mother 
cell, can be inherited precisely by its daughter cells (9). 
However, it is important to understand that these epigenetic marks can persist and 
influence a gene state, making it active or silent, even after many cell divisions.  
 
1.2. DNA methylation  
The methylation of cytosine residues in DNA molecules was the first epigenetic 
discovery. DNA methylation is linked to transcriptional silencing, and is important for 
gene regulation, development, and tumorigenesis (8,16,17). 
This epigenetic regulation mechanism relies on the activity of DNA 
methyltransferases (DNMTs), that are responsible for the transfer of a methyl group to 
DNA and are essential for mammalian development (18). Nearly all DNA methylation 
occurs on cytosine residues that are located side by side with guanine residues, forming 
cytosine-phosphate-guanine (CpG) dinucleotides, which usually appear heavily repeated 
in genomic sequences and are called CpG islands. Usually these regions are preferably 
found in non-coding regions of the genome. In coding ones, they are almost exclusively 
in 5’ ends, like promoters, 5’ untranslated regions (5’ UTR) or the exon 1 of human 
genes, and their methylation degree might prevent gene expression (8). However, there 
are other genomic regions affected by DNA methylation, located nearby CpG islands, 
but with less CpG dinucleotides, termed CpG shores. Indeed, these regions may also 
regulate gene expression. 
Methylation is a reversible reaction, and so demethylation might also take place, 
promoting the activation of gene transcription. This process is mediated by the action of 
TET family proteins or by GADD45 family members (14). 
DNA methylation may prevent expression, either directly through transcriptional 
activators’ obstruction, or indirectly by recruitment of methylcytosine-binding proteins. 
Furthermore, these may promote the enrolment of more DNMTs and histone 
deacetylases (HDAC), which might result in additional chromatin alterations, that will 
further repress transcription (14). 
In mammalian cells, methylation of cytosine residues is catalysed by DNMTs, 
including DNMT1, DNMT3a and DNMT3b (8,19). Wherein, the DNMT3a and 
DNMT3b are involved in de novo methylation, which may occur in embryonic stem 
cells or cancer cells (19). While the DNMT1 maintains the genomic methylation state 
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by specifically recognizing and methylating hemimethylated CpG dinucleotides during 
DNA replication (20–22). 
The association between DNA methylation and disease is that aberrant patterns of 
DNA methylation influence many aspects of disease processes, through altered gene 
expression profiles, particularly in many human tumours (16,17,23). Cancers have the 
unique property of being globally hypomethylated, which alters the chromatin 
architecture, leading to the inappropriate activation of oncogenes. In contrast, specific 
hypermethylation and hence silencing of tumour suppressor genes is recognized as a 
hallmark of many types of cancer cells (8,24,25). 
DNA methylation can also be a plausible explanation for the phenomenon of 
epigenetic memory, because it is associated with gene silencing. During DNA 
replication, each daughter cell will have one parental DNA strand, which carries the 
mother cell’s DNA methylation pattern; and one newly synthesized DNA strand, which 
is at first unmethylated (3). As previously mentioned, these hemi-methylated sites are 
the preferential substrates of DNA methyltransferase (DNMT), DNMT1 and 
consequently the DNA methylation pattern in daughter cells will be faithfully replicated 
from the mother cell, hence explaining the epigenetic memory (8). 
In the "Roadmap Epigenomics Consortium" that is the database we use, DNA 
methylation is assayed by sequencing DNA using three different methods: BS-seq; 
MeDIP-seq; and MRE-seq. 
 BS-seq 
A gold-standard technology for detection of DNA methylation is bisulfite genomic 
sequencing, because it provides a qualitative, quantitative and efficient approach to 
identify 5-methylcytosine (5mC) at single base-pair resolution. Frommer et al (1992), 
was the first to introduce this method which is based on the finding that the amination 
reactions of cytosine and 5-methylcytosine proceed with very different consequences 
after the treatment with sodium bisulfite (26,27). 
The process consists of cytosines in single-stranded DNA that will be converted 
into uracil and recognized as thymine in the subsequent polymerase chain reaction 
(PCR) for amplification and sequencing. However, 5mCs are immune to this conversion 
and remain as cytosines allowing 5mCs to be distinguished from unmethylated 
cytosines after sequencing.  To determine the methylation status in the loci of interest 
by using specific methylation primers after the bisulfite treatment is necessary the PCR 
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process. The actual methylation status can be determined either through direct PCR 
product sequencing (detection of average methylation status) or sub-cloning sequencing 
(detection of single molecules distribution of methylation patterns), as can be seen in 
figure 5. Furthermore bisulfite sequencing analysis (see example in figure 6) can 
identify the DNA methylation status along the DNA single strand, and can also detect 
the DNA methylation pattern of DNA double strands since the converted DNA strands 
are no longer self-complementary and the amplification products can be measured 
individually (27,28). 
 
 
 
Figure 5: Principles of methylation analysis using bisulfite genomic sequencing. After treatment 
with sodium bisulfite, unmethylated cytosine residues are converted to uracil whereas 5mC remains 
unaffected. After PCR amplification, uracil is converted to thymine. The DNA methylation status 
can then be determined by direct PCR sequencing or cloning sequencing. Adapted image (27). 
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Figure 6: Interpretation of methylation sequencing results. DNA methylation status can be 
interpreted by comparing the sequencing results and the original DNA sequence. Fundamentally, 
all unmethylated C convert to T and the presence of a C-peak indicates the presence of 5mC in the 
genome. But, if both C-and T-peaks appear, this indicates that partial methylation or potentially 
incomplete bisulfite conversion has occurred. The proportion of 5mC to C can be interpreted by 
analysing the relative square area of these two bands. Adapted image (27). 
 
Bisulfite-based DNA methylation analyse are more quantitative, sensible, efficient, 
and allows for a wide spectrum of sample analyses, compared with other DNA 
methylation approaches, some of them based on the sensitivity of restriction enzymes 
that can specifically recognize methylated cytosines within their cleavage recognition 
sites (28–33). Therefore, this method is the golden standard for DNA methylation 
analysis and has been widely used in various research and clinical settings. 
 
 MeDIP-seq and MRE-seq 
These two methods (as we can see in figure 7) have their own advantages and 
disadvantages, and can be applied independently or jointly. However, Li D. et al (2011), 
suggest that by integrating these two complementary technologies, we can effectively 
improve the coverage and resolution of the DNA methylomes produced, and improve 
the accuracy of detection of differentially methylated regions (34).  
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The MRE-seq (see in example in figure 8) gives DNA methylation estimates at 
single CpG resolution, but its coverage is low due to the limit of CpG containing 
recognition sites. As to MeDIP, it has an important advantage over enzymatic digestion-
based methods which is the lack of bias for a specific nucleotide sequence, other than 
CpGs. However, the relationship of enrichment to absolute methylation levels is 
confounded by variables such as CpG density. Another limitation of MeDIP-seq is its 
lower resolution (~150bp) compared to MRE-seq or bisulfite-based methods since one 
or more of the CpGs in the immunoprecipitated DNA fragment can be the responsible 
for the antibody binding (28,34,35). 
 
 
Figure 7: Workflow of combined MeDIP-seq and MRE-seq. Genomic DNA is frist isolated and 
purified. For MeDIP-seq genomic DNA is sonicated to a specific size range, and a monoclonal anti-
5’methylcytosine antibody is used to enrich the sample in methylated DNA fragments. This 
immunoprecipitated DNA fragments are sequenced and mapped back to the reference genome 
assembly to discover methylated regions. For MRE-seq genomic DNA is sonicated to a specific size 
range, and a monoclonal anti-5’methylcytosine antibody is used to enrich the sample in methylated 
DNA fragments. This immunoprecipitated DNA fragments are sequenced and mapped back to the 
reference genome assembly to discover methylated regions. Both the MeDIP-seq as MRE-seq data 
can then be integrated by applying methylCRF, which transform enrichment-based DNA 
methylation data to methylation level at single CpG resolution across the genome. To compare two 
samples and detect differentially methylated regions, M&M is applied in a region-specific fashion, 
for example. Adapted image  (34). 
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Figure 8: Example of a MRE-seq file, which will be used in this work, related to breast stem cells. 
First column shows the chromosome (chromosome 1), second column the first position and third 
column the last position of DNA restriction site. Image taken from MATLAB. 
 
1.3. Small RNAs 
There is growing evidence that dynamic changes on chromatin, chromosomes and 
nuclear architecture are regulated by RNA signalling. Indeed, through small non protein 
coding RNAs (ncRNAs), regulation can occur at some of the most important levels of 
genome function, including chromatin structure, chromosome segregation, transcription, 
RNA processing, RNA stability, and translation (36,37).  
While the precise molecular mechanisms are not yet well understood, they appear 
to involve the differential recruitment of a hierarchy of generic chromatin modifying 
complexes, and DNA methyltransferases to specific loci by RNAs during differentiation 
and development. A significant fraction of the genome-wide transcription of ncRNAs 
may be involved in this process, comprising a previously hidden layer of intermediary 
genetic information that underpins developmental ontogeny and the differences between 
species, ecotypes and individuals (36,37). 
In addition, RNA-directed regulatory processes may also transfer epigenetic 
information not only within cells but also among cells and organ systems, as well as 
across generations. 
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Therefore, small ncRNAs have an important role in regulating gene expression and 
many classes of small RNAs have been described. There is general recognition of three 
main categories the small ncRNAs, differing on various aspects of their origins, 
structures, associated effector proteins, and biological roles: short interfering RNAs 
(siRNA), microRNAs (miRNA) and piwi interacting RNAs (piRNA), which are 
described in detail in annex 2. 
The processes directed by these small RNAs will confer resistance to a variety of 
cellular insults, such as viral infection, and prevent random transposition events within 
the genome. In addition, small RNAs have been shown to be important for directing 
other epigenetic processes, such as DNA methylation and chromatin modification, as 
mentioned above (28,36,37). 
 
These three mechanisms of epigenetic regulation (DNA methylation, histone 
modifications and chromatin structure, and finally small RNAs), contribute to the 
epigenome, which is like a computer program that regulates the functioning of the genes 
themselves. The distribution of methylated DNA, histone modifications, and ncRNA 
expression may not only be specific to a particular organism, but it will be specific to a 
particular tissue, or even one particular cell type. Misregulation of these epigenetic 
events has been observed in various cancers and human diseases. So, understanding 
how the epigenome contributes to gene regulation will give us greater insight into the 
thin frontier between human health and disease. 
 
1.4. General objectives 
The work described in this dissertation aimed to study the epigenetic signals of the 
human genome, to observe the dependence between the context and the occurrence of 
epigenetic marking and, if possibly, to identify specific contexts related to genomic 
modification of histones. 
Thus, the main objectives of this work were: 
 Obtain the frequency of oligonucleotides, in marked regions and unmarked 
regions. 
 Using statistical methods, such as statistical tests, residue analysis, effect 
size measures and hierarchical classification, comparing the genomic 
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context of epigenetic marking among chromosomes and among 
epigenomes. 
 Create a control dataset to complement the analysis. 
 Statistical evaluation. 
 
1.5. Dissertation structure 
As mentioned earlier, this work consists on the determination of genomic contexts 
specific of epigenetic markings of histone modifications. To do this it was necessary to 
developed some R scripts in program R (described in Chapter 3), so as to obtain the 
frequencies of oligonucleotides. 
Firstly, it was necessary to obtain of histone modifications in public databases 
(described in Section 2). Then, we obtained the frequency of oligonucleotides of those 
fragments (described in Chapter 3) and then we summed the total of such frequencies. 
In order to obtain these results, we used the statistical methods described in Chapter 3. 
This dissertation is divided into three chapters and annexes: 
 In chapter 1 it is introduced the theme of the dissertation and the general 
objectives are presented. 
 In chapter 2 ("Roadmap Epigenomics Consortium") is presented the 
database we use, as well as a description of the available and used files. 
 In chapter 3 ("Analysis of epigenomes") it is presented a description of the 
tools used as well as the statistical procedure. This chapter will also present 
the results obtained. 
 In chapter 4 ("Discussion") the main conclusions obtained is this work are 
presented and also ideas for future work. 
 Annex 1 ("Modifications of histones") presents a detailed description of each 
histone modification. 
 Annex 2 ("The three main categories of small ncRNAs") presents the 
description of each category the small ncRNAs. 
 Annex 3 ("The various tissues present in Consortium") presents the 
description of each cell line used in the study. 
 Annex 4 ("Characteristics of each histone modification") presents the main 
characteristics of each histone modification studied in this dissertation 
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 Annex 5 (“R scripts”) describes each R script used and presents their 
functions. 
 Annex 6 ("Histone union and histone intersection") presents the results 
obtained for histone union and histone intersection, using the chi-square test 
and measure of association Cramer's V.  
 Annex 7 ("Comparing to the histone with each control") presents the results 
of comparing each histone modification with the control through the chi-
square test and the measure of association Cramer's V. 
 Annex 8 ("Heatmaps") presents examples of heatmaps about the genomic 
context of epigenetic marking. 
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2. Roadmap Epigenomics Consortium 
2.1. Project description 
The NIH Roadmap Epigenomics Mapping Consortium was designed, in 2008, to 
produce a database of human epigenomic data in order to encourage biology and 
research associated with the disease (38,39).  
These epigenomic maps, “offer broad insight into genome regulation and are 
generally available for diverse cell populations”. The Consortium includes genomic 
maps for:  (39): 
i. DNA methylation: assayed by sequencing DNA that has been treated with 
sodium bisulfite (BS-seq), or enriched in methylated cytosines by 
methylcytosine pull down (methylated DNA immunoprecipitation (MeDIP-
seq)) or methylation-sensitive restriction reactions (MRE-seq).  
ii. Histone modifications: assayed by sequencing DNA enriched by chromatin 
immunoprecipitation with modification-specific histone antibodies (ChIP-
seq).  
iii. Chromatin accessibility: assayed by sequencing DNase I cleavage sites in 
nuclear chromatin.  
iv. RNA expression: assayed by sequencing mRNAs or size-selected small 
RNA fractions to high depths. These expression data are intended to 
augment and illuminate the functional output of the epigenomic profiles. 
The Consortium investigate a diverse set of cell and tissue models (Table 1), These 
cells and tissues were prioritized on the basis of broad scientific and biomedical interest. 
All cell lines are described in detail in annex 3. 
 
Adrenal – Fetal 
 Fetal, Adrenal Gland 
Brain 
 Brain Anterior Caudate  
 Brain Cingulate Gyrus  
 Brain Hippocampus Middle  
 Brain Angular Gyrus  
 Brain Inferior Temporal Lobe  
 Brain Germinal Matrix  
 Brain Mid Frontal Lobe  
 Brain Substantia Nigra  
 Neurosphere Cultured Cells Cortex Derived  
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 Neurosphere Cultured Cells Ganglionic Eminence Derived  
 Brain Cerebellum 
Brain – Fetal 
 Fetal, Brain  
 Fetal Spinal Cord 
Breast  
 Breast Stem Cells 
 Breast Myoepithelial Cells  
 Breast Luminal Epithelial Cells  
 Breast vHMEC 
ES Cells 
 H1  
 H9  
 HUES1  
 HUES3  
 HUES6  
 HUES8  
 HUES9  
 HUES13  
 HUES28  
 HUES44  
 HUES45  
 HUES48  
 HUES49  
 HUES53  
 HUES62  
 HUES63  
 HUES64  
 HUES65  
 HUES66  
 ES-I3 Cell Line  
 ES-WA7 Cell Line  
 UCSF-4Star 
ES – Derived Cells 
 H1 Derived Embryoid Body Cultured Cells  
 H9 Derived Embryoid Body Cultured Cells  
 HUES1 Derived Embryoid Body Cultured Cells  
 HUES3 Derived Embryoid Body Cultured Cells  
 HUES6 Derived Embryoid Body Cultured Cells  
 HUES45 Derived Embryoid Body Cultured Cells  
 H1 Derived Neuronal Progenitor Cultured Cells  
 H9 Derived Neuronal Progenitor Cultured Cells  
 H9 Derived Neuron Cultured Cells  
 H1-BMP4  
 hESH1 derived mesenchymal  
 hESH1 derived mesendoderm  
 hESC Derived CD184+ Endoderm Cultured Cells  
 hESC Derived CD56+ Mesoderm  
 hESC Derived CD56+ Ectoderm Cultured Cells 
Exocrine – Endocrine 
 Adrenal Gland  
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 Pancreas 
 Spleen  
 Thymus 
Fat – Adult 
 Mesenchymal Stem Cell Derived Adipocyte Cultured Cells  
 Adipose Nuclei  
 Adipose Derived Mesenchymal Stem Cell Cultured Cells  
 Adipose Tissue 
GI – Adult 
 Liver, Adult  
 Stomach Smooth Muscle  
 Duodenum Mucosa  
 Duodenum Smooth Muscle  
 Pancreatic Islets  
 Colonic Mucosa  
 Rectal Mucosa  
 Rectal Smooth Muscle  
 Colon Smooth Muscle  
 Esophagus  
 Gastric  
 Sigmoid Colon  
 Small Intestine 
GI – Fetal 
 Fetal, Intestine Large  
 Fetal, Intestine Small  
 Fetal, Stomach 
GU – Adult 
 Kidney, Adult  
 Bladder 
Heart – Adult 
 Aorta  
 Heart  
 Left Ventricle  
 Right Atrium  
 Right Ventricle 
Heart – Fetal 
 Fetal, Heart 
Hematopoietic Stem  
 CD34, Primary Cells  
 CD34, Mobilized Primary Cells  
 CD34, Cultured Cells 
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IPs Cells 
 IPS 4.7  
 IPS 6.9  
 IPS-11a  
 IPS-11b  
 IPS-11c  
 IPS-15b  
 IPS-17a  
 IPS-17b  
 IPS-18a  
 IPS-18b  
 IPS-18c  
 IPS-19.7  
 IPS-19.11  
 IPS-20b  
 IPS-27b  
 IPS-27e 
Kidney – Fetal 
 Fetal, Kidney  
 Fetal, Kidney Left  
 Fetal, Kidney Right  
 Fetal, Renal Cortex  
 Fetal, Renal Cortex Left  
 Fetal, Renal Cortex Right  
 Fetal, Renal Pelvis  
 Fetal, Renal Pelvis Left  
 Fetal, Renal Pelvis Right 
Lung – Adult 
 Lung 
Lung – Fetal 
 Fetal, Lung  
 Fetal, Lung Left  
 Fetal, Lung Right  
 Fetal, Lung Fibroblast (IMR90) 
Muscle -  Adult 
 Skeletal Muscle  
 Muscle Satellite Cultured Cells  
 Psoas Muscle 
Muscle -  Fetal 
 Fetal, Muscle Arm  
 Fetal, Muscle Back  
 Fetal, Muscle Leg  
 Fetal, Muscle Lower Limb  
 Fetal, Muscle Upper Limb  
 Fetal, Muscle Trunk  
 Fetal, Muscle Upper Trunk 
Placenta – Fetal 
 Fetal, Placenta  
 Placenta Amnion  
 Placenta Basal Plate  
 Placenta Chorion Smooth  
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 Placenta Trophoblast Primary Cells  
 Placenta Villi 
Reproductive – Adult 
 Ovary  
 Testis Spermatozoa Primary Cells 
Reproductive – Fetal 
 Fetal Ovary 
Skin – Fetal 
 Fibroblasts Fetal Skin Abdomen  
 Fibroblasts Fetal Skin Biceps Left  
 Fibroblasts Fetal Skin Biceps Right  
 Fibroblasts Fetal Skin Quadriceps Left  
 Fibroblasts Fetal Skin Quadriceps Right  
 Fibroblasts Fetal Skin Upper Back  
 Fibroblasts Fetal Skin Upper Back 
Spleen – Fetal 
 Fetal, Spleen  
 Fibroblasts Fetal Skin Back 
Stromal – Connective 
 Bone Marrow Derived Mesenchymal Stem Cell Cultured Cells 
 Chondrocytes from Bone Marrow Derived Mesenchymal Stem Cell Cultured Cells  
 Primary Fibroblast  
 Fetal Skin  
 Foreskin Fibroblast Primary Cells  
 Foreskin Keratinocyte Primary Cells  
 Foreskin Melanocyte Primary Cells  
 Breast Fibroblast Primary Cells 
Thymus – Fetal 
 Fetal, Thymus 
White Blood  
 CD3+ Total Unmobilized  
 CD3+ Total Mobilized  
 CD8, Primary Cells  
 CD8, Naive Primary Cells  
 Mobilized CD8 Primary Cells  
 CD4, Primary Cells  
 CD4, Mobilized Primary Cells  
 CD4, Memory Primary Cells  
 CD4+ CD25- CD45RA+ Naive Primary Cells  
 CD4, Naive Primary Cells  
 CD4+ CD25+ CD127- Treg Primary Cells  
 Treg Primary Cells  
 Th17 Primary Cells  
 CD4+ CD25- IL17+ PMA-Ionomcyin stimulated Th17 Primary  
 CD4+ CD25- CD45RO+ Memory Primary Cells  
 CD4+ CD25- IL17- PMA-Ionomycin stimulated MACS purified Th Primary Cell  
 CD4+ CD25- Th Primary Cells  
 CD4+ CD25int CD127+ Tmem Primary Cells  
 CD14, Primary Cells  
 CD56, Primary Cells  
 CD8, Mobilized Cells  
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 CD15, Primary Cells  
 CD19, Primary Cells  
 CD20, Primary Cells  
 CD56, Mobilized Cells  
 Peripheral Blood Mononuclear Primary Cells  
 CD4+ CD25- CD45RA+ Naive Primary Cells  
 CD4+ CD25- CD45RO+ Memory Primary Cells 
Table 1: Diverse set of cell and tissue models available in the Roadmap Database. 
 
2.2. Description of data 
Regarding the files found in the NIH Roadmap Epigenomics Mapping Consortium 
database, it is important to know that DNA sequencers are devices that read a DNA 
sample and generate an electronic file with symbols representing the sequence of 
nitrogenous bases – A, C, G, and T - in the sample. Each sequencing technology has a 
different strategy, but normally we can identify commons steps between all sequencers: 
sample preparation, amplification and preparation of the sequencing library (40), 
sequencing reaction and data analysis.  
In the consortium database we can find four types of files: 
 Sequence Read Archives (SRA): raw DNA fragments. 
 Wiggle format (WIG): fragments already mapped on the reference genome. 
 Binary SAM (BAM): fragments already mapped on the reference genome. 
 BED: annotation file. 
The linear sequence of bases which make up the genome is only the first level of 
genetic information, where genes and gene expression regulatory elements are encoded. 
To identify the position of these elements, we use annotation files, which often are 
nothing more than text files that associate genomic coordinates to genetic characteristics 
or features. 
The BED format (see example in figure 9) is one of these annotation file formats. It 
was created by UCSC to describe and annotate a genome and is the type of file that we 
will use in this work. It is a format that can be read by the UCSC browser and has 
various fields that describe the graphical representation of the information. It is a text 
format, with columns separated by tab characters representing breaks in the genome 
associated with the annotation or feature. There are three variations of bed format, the 
standard version, the version bedDetail/bedGraph, and a binary version called bigBed 
(40). 
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In common, all bed formats have the following columns: 
1) chrom: chromosome scaffold or name. 
2) chromStart: beginning of an annotation position (starting at 0) 
3) chromEnd: last position of an annotation. 
In describing the features that it contains, a bed file may have a header that begins 
with the word track and depicts other attributes used for the graphic representation of 
regions, in the genome browser. 
 
 
Figure 9: Example of a bed file, that will be used in this work, related to the H1 cell line and the 
histone modification H3K4me1. The first column indicates the chromosome (chromosome 15), the 
second column, the initial position, and the third column, the final position of the DNA fragment 
contacting the modification histone, and the last column, shows the study  (USSC), cell line (H1), 
histone (H3K4me1) and specificity (LL228). Image taken from MATLAB. 
 
In bedDetail form at other two columns are added thus having the following 
structure (see example in figure 9): 
1) chrom: chromosome scaffold or name. 
2) chromStart: first annotation position (starting at 0) 
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3) chromEnd: last position of an annotation. 
4) Name: Name of the region and metadata. 
5) Strand of DNA: + or - 
This type of file is usually organized in 3 levels: Study – Sample – Experiment. In 
this work we use:  
 Study: all studies (BI, UCSC, USCF-UBC and UW). 
 Sample: all histone with bed files. 
 Experiment: all experiment data with bed files. 
 
2.2.1. Modification of histones 
In this project were studied 31 histone modifications as shown in table 2, these 
histones are distributed by different cell types (adult and fetal) (see example in figure 
10). Annex 4 shows additional characteristics of each histone modification. 
 
 
H2A.Z H3K18ac 
H2AK5ac H3K23ac 
H2AK9ac H3K23me2 
H2BK5ac H3K27ac 
H2BK12ac H3K27me3 
H2BK15ac H3K36me3 
H2BK20ac H3K56ac 
H2BK120ac H3K79me1 
H3K4ac H3K79me2 
H3K4me1 H3T11ph 
H3K4me2 H4K5ac 
H3K4me3 H4K8ac 
H3K9ac H4K12ac 
H3K9me1 H4K20me1 
H3K9me3 H4K91ac 
H3K14ac  
Table 2: Histone modifications studied in this project. Two examples:  H3K4me1: Histone H3 
monomethylated at lysine 4; H3K27ac: Histone H3 acetylated at lysine 27. 
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Figure 10: This project used different kinds of histone modifications, depending on the tissue, and 
the cell type. For example: The brain is represented by 7 histone modifications (H3K27me3, 
H3K36me3, H3K4me1, H3K4me3, H3K9ac, H3K9me3 and H3K27ac). It also shows the Bisulfite-
Seq, MeDIP-seq and MRE-Seq are three methods for assay the sequencing DNA. RRBS is the 
reduced representation bisulfite sequencing. The chromatin accessibility can be assayed by 
sequencing DNase I. RNA expression can be assayed by sequencing mRNAs (mRNA-Seq) or size-
selected small RNA fractions to high depths (smRNA-Seq). And finally, Histone modifications can 
be assayed by sequencing DNA enriched by chromatin immunoprecipitation with modification-
specific histone antibodies (ChIP-seq). The histone modifications are experiments, or whatever it is 
horizontal. And what is vertical are the samples. Imagen taken from the Roadmap Epigenomics 
(41). 
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3. Analysis of epigenomes 
The main objective of this work is to study the epigenetics signals in the human 
genome, meaning, whether there is dependence between the DNA sequence and the 
occurrence of epigenomic marking. The present study employed different statistical 
methodologies, namely, statistical tests, effect size measures, residue analysis and 
hierarchical classification. With these methodologies, we compared genomic contexts of 
epigenetic marking among chromosomes and among different histone modifications, 
complementing the analysis with a control scenario, with no markings and factoring the 
C+G content. 
 
3.1. Software tools 
In order to analyse the epigenomic data and to perform statistical analysis, we used 
the R program, a free software for statistical computing and graphing, that  have 
programming language named "S", that is simple and effective. This program obtains 
data manipulation, calculation. It contains tools and graphics for data analysis and their 
display (42).  
In order to accomplish the desired statistical analysis, we had to install some 
packages, such as Biostrings gives an evolved environment for efficient flow 
management and analysis in R It has many utilities, such as many speed and memory 
effective and string matching algorithms  for fast manipulation of large sets of 
sequences (43). Through objects and functions provided by Biostrings originates many 
other sequence analysis packages. Also, this package allows to exclude undesired 
regions through mask XString objects, so that these masks can be turned on and off any 
time. The XSTring also allows to represent the different types of biosequence strings in 
subclasses: BString, RNAString, DNAString and AAString. Biostrings  contains 
functions for performing many of the basic sequence transformation and manipulation 
routines and it makes also possible performing multiple sequence alignments (43).  
Another package used was WriteXLS, which serves to create an Excel file with 
data obtained from the R program (44). Package XLSX, was also used with the 
objective of working with the Excel file data in R program (45).  
Another important package used was the “GenomicRanges package that defines 
general purpose containers for storing and manipulating genomic intervals and variables 
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defined along a genome” (46). This package serves as the foundation for representing 
genomic locations within the Bioconductor project, giving tools for the analysis and 
comprehension of high-throughput genomic data. “The Bioconductor hierarchy, is built 
upon the IRanges (infrastructure) function and provides support for the BSgenome 
(infrastructure) and GenomicFeatures (infrastructure) functions, and many other 
functions”. The IRanges package introduces three classes (GRanges, GPos, and 
GRangesList), which are used to represent genomic ranges, genomic positions, and 
groups of genomic ranges, respectively (46). We used the “GRanges class that 
represents a collection of genomic ranges where each have a single start and end 
location in the genome”. Therefore, it may be used to store the location of genomic 
features, for example, contiguous binding sites, transcripts, and exons (46). 
In order to analyse the genomic context of epigenetic marking, we used some R 
scripts in the program R. One of these altered columns that were relevant of the 
analysis, because the database provided additional information that was not needed. 
Another R script was created to obtain the frequency of oligonucleotides, i.e. single 
nucleotides, dinucleotides, trinucleotides and tetranucleotides. Wherein, first we 
obtained the frequency of oligonucleotides for fragment, where each fragment is a 
regional a chromosome with start and an end position. This function counted the 
frequency of oligonucleotides contained in that space (between the initial position and 
the end position). To obtain the full frequency of oligonucleotides for the chromosome 
1, for example, the total of the fragments present in this chromosome was summed.  
Besides these two R scripts mentioned here, we used others, which are described in 
detail annex 5. 
 
3.2. Statistical procedures 
In this work we have used t-test, Cohen's d, chi-square test, Cramer’s V, residual 
analyses and hierarchical clustering, to explore the possibility of dependence between 
DNA contexts and epigenetic marking occurrence.   
 
3.2.1. Effect size 
The effect size is a measure independent of the sample size that quantifies the force 
with which a phenomenon of interest occurs, that is, it is a descriptive statistic that 
serves as a complement to the test of statistical significance (47). The Cohen's d is one 
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effect size measure, which can be used to complement t-test results for example, by 
evaluating the mean difference between two groups. The Cohen’s d measure is 
arbitrarily classified. One common classification of Cohen's d effect size is: 
(d = 0.8)  large  
(d = 0.5)  moderate  
(d = 0.2)  small 
So, in these statistical analyses we calculated the Cohen’s d, using the equation: 
 
𝑑 =  
ꭓ1̅ −  ꭓ2̅̅̅
𝑠𝑝𝑜𝑜𝑙𝑒𝑑
 
 
Where: 
𝑆𝑝𝑜𝑜𝑙𝑒𝑑 = √
𝑆1
2(𝑛1 − 1) + 𝑆2
2(𝑛2 − 1)
𝑛1 + 𝑛2 − 2
 
 
ꭓ1̅e ꭓ2̅̅̅- The mean of the group 1 and group 2, respectively. 
𝑆1
2e 𝑆2
2- The sample variances of the group 1 and group 2, respectively. 
𝑛1 e 𝑛2- The sample sizes in the group 1 and group 2, respectively. 
 
The concept of contingency table will also be required from now on. This is a type 
of table, in a matrix format, that displays the frequency distribution of two variables and 
can be represented generically by as in table 3: 
 
 
  
  
Y 
  
       …     
 
  
 
… 
 
  
X 
…
 
 
  …
 
     … 
 
  
 
    …     
 
  
   
  
 
Table 3: The contingency table. 𝒏𝒊𝒋 – Total of observations; 𝒏𝒊. – The total observations in the 
category i variable row; 𝒏.𝒋 – The total of observations in the category j variable column. 
 
𝑥𝑖 
𝑥𝑟 
𝑦𝑗 𝑦𝑐 
𝑛𝑟𝑐 𝑛𝑖𝑐 
𝑛𝑟𝑗 𝑛𝑟𝑐 
𝑛.𝑗 𝑛.𝑐 
𝑛𝑖. 
𝑛𝑟. 
𝑛𝑖𝑗 
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Cramer's V is another effect size measurement, which is associated with the chi-
square test. Alternatively one can also use phi coefficient. The Cramer's V describes the 
combination of intensity in the sample and takes values between 0 and 1. The 0 value 
corresponds to the absence of association between variables, near zero values 
correspond to weak association and values closer to 1 values correspond to strong 
association (48). As with Cohen’s d the classification of the V effect force is also 
subjective, so one frequent classification associated with biological sciences is as 
follows: 
  (V ≈ 0.1)  Weak association 
  (V ≈ 0.3)  Moderate association 
  (V ≈ 0.5)  Strong association 
In this work, we considered that the Cramer’s V assumed a negligible value if 
lower than 0.001, and for values bigger than 0.001 will not be considered negligible. 
This measure of association is calculated by: 
 
𝑉 =  √
𝑋2
𝑛(𝐾 − 1)
 
n- Total of observations 
K- The minimum {c, r} 
 
 
 
On the other hand, the phi coefficient can be calculated by: 
 
Φ =  √
𝑋2
𝑛
 
n- Total of observations 
 
It is important to highlight that small and very small effects may be significant, 
because just for this that the sample size is large enough. Herein, in order to make a 
more complete analysis, the results of statistical tests will always be supplemented with 
the values of the corresponding measures of effect size. 
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3.2.2. Statistical test 
For statistical testing it is important to define the null hypothesis and in turn, the 
alternative hypothesis. The null hypothesis (H0) must be formulated in order to be 
rejected, if an effect exists. Otherwise, the test won't add nothing about the 
characterization of the population (48,49). Conversely, the alternative hypothesis (H1) is 
associated with the theory to demonstrate (48,49). 
In addition to defining H0 and H1, to perform the hypothesis test it is also necessary 
to establish a level of significance (α). After words, the decision of the hypothesis test is 
based on the p value. The hypothesis H0 is rejected if the p value is less than the 
significance level, and the most used significance levels are 5%, 1% and 10% (48,49). 
We used the t-test with the aim of comparing two independent samples. This test 
compared the average of a quantitative variable in two different groups of subjects and 
is unaware of their variances. The conditions for its use are: 
i. Two independent aleatory samples; 
ii. Two populations normally distributed with unknown variance. 
The t-test is calculated by: 
 
𝑇 =  
𝑑
√
1
𝑛1
+
1
𝑛2
 
 
𝑛1 e 𝑛2- The sample size of the group 1 and group 2, respectively. 
 
The chi-square test serves to test if the distributions of two or more unrelated 
samples differ significantly. However, this test can also be used to test the independence 
between two variables or the homogeneity between groups (48,49).  
The conditions for the use of this test are:  
i. Exclusively for nominal and ordinal variables;  
ii. Preferably for large samples, >30;  
iii. Independent observations;  
iv. It does not apply if 20% of the expected values are below 5. 
We can calculate the chi-square value, using the formula: 
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𝑋2 = ∑
(𝑂 − 𝐸)2
𝐸
 
O- Observed values 
E- Expected values 
 
High statistical values lead to the rejection of the H0 (the hypothesis of 
independence and equality in the distribution of different groups), for the benefit of H1. 
 
3.2.3. Residual analysis 
With the purpose of identifying the categories responsible for a significant value of 
the statistical chi-square, test a process that involves the analysis of normalized 
residuals is used. The normalized residuals are calculated as follows: 
𝑟𝑖𝑗 =  
𝑛𝑖𝑗 −  𝑒𝑖𝑗
√𝑒𝑖𝑗
 
 
𝑛𝑖𝑗 - Total observations in contingency lines and columns. 
𝑒𝑖𝑗 - Expected frequencies. 
 
To find the expected value, the following formula is used: 
 
𝑒𝑖𝑗 =
𝑛𝑖. ∗ 𝑛.𝑗
𝑛
 
 
𝑛𝑖.– The total observations in the category i variable row. 
𝑛.𝑗– The total of observations in the category j variable column. 
 
An estimate of the variance of  𝑟𝑖𝑗 can be obtained using: 
 
𝑣𝑖?̂? =  (1 −
𝑛𝑖.
𝑛
) (1 −
𝑛.𝑗
𝑛
) 
 
Then, for each cell of the contingency table, we can calculate the standardized 
residual (𝑑𝑖𝑗) using: 
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𝑑𝑖𝑗 =  
𝑟𝑖𝑗
√𝑣𝑖?̂?
 
 
To interpret a residual analysis in the context of contingency tables, a heatmap can 
be created in R program, which is a two-dimensional representation of data in which 
values are represented by colours to indicate the level of intensity. Normally, darker 
colours indicate lower effect size, while brighter colours indicate higher effect size. 
 
3.2.4. Clustering methods 
The clustering methods that were used are hierarchical methods that result in 
partition hierarchies. Hierarchical methods can be further subdivided into agglomerative 
and divisive methods (50). The application of agglomerative methods starts with a 
partition with as many parts as the number of different individuals that will because 
grouped, while the divisive methods considers as a starting point a partition with a 
single group, a single set including all individuals that will be divided in hierarchical 
groups (50). 
In this work we have used a process of grouping or aggregation that determines 
similarities between individuals using a similarity measure and performs the grouping 
of subjects in groups via an aggregation policy so that they can be represented by a 
dendrogram (50). The dendrogram has the advantage of facilitating viewing of the 
clustering process in its various phases from separate individuals to a single a unified 
group. In fact, the dendrogram is a graphical representation of a partition hierarchy, 
wherein each group is called a cluster. 
We have chosen agglomerative methods, since these are the most used and most 
reported in the literature. One of the reasons for this is that it needs less computational 
effort for the same kind of analysis. The clustering algorithms group data according to 
similarity indices. 
For agglomerative methods there are several aggregation criteria, and what 
distinguishes them is the way of setting distance between groups (50). Examples of 
aggregation criteria are single linkage, complete linkage and average. 
 Single linkage: is one of the simple algorithms for hierarchical clustering 
and used the nearest neighbor technique, i.e. the distance between two 
clusters is determined by the distance between the closest groups. However, 
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using this algorithm, in the presence of distant groups located between two 
clusters, it forms a bridge and force an inappropriate combination of these 
clusters – the so called chaining effect (50). 
 Complete linkage: it is known as the technique of the farthest neighbor, 
since it determines the distance between two clusters according to the 
longest distance between a pair of groups, a mode most likely to identify 
clusters that are less extended (50). 
 Average linkage: Under this option, the distance between two clusters is 
defined as the average of the distances between all sample pairs on each 
cluster (50). 
One cannot say that there is a criterion of aggregation that is better than the others, 
that is, in practice, what is done is to use multiple criteria and to compare the results. If 
the results obtained with different criteria are concordant the end result can be 
considered "more credible". 
Finally, when data are organized in attribute-value tables, their attributes can take 
different types: binary, discrete or continuous. Binary attributes assume only two 
values, for example yes and no or 1 and 0, indicating the presence or absence of a 
particular feature. Discrete attributes have often a finite and small set of possible values. 
Continuous attributes can take any real value in one of a pre-defined range, which will 
be our case. The interpretation of dendograms varies with the methods of similarity and 
different grouping techniques used. For example, complete linkage clustering should 
produce higher distance values between large clusters, while a dendrogram generated by 
the single link algorithm tends to have smaller distance values for the same cluster (50). 
 
3.3. Procedure used for epigenomes analysis 
3.3.1. Epigenomic regions manipulation 
In order to analyse all epigenomes, we decided to use both the union and the 
intersection. The union is when two or more sets are put together, establishing a 
common relationship between its elements. The intersection is when two or more 
elements are common to related sets. In our analysis we have: 
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 Global union and global intersection will be used for the analysis of whole 
genome, focusing on the context epigenetic marking on chromosomes, as 
exemplified in figure 11: 
 
  
               Location of an epigenetic mark. 
        K - Total of experiments used. 
Figure 11: Global union and global intersection will be used for the analysis of whole genome.  The 
fragments are pieces of DNA that can be there this epigenetic marking. 
 
 Histone union and histone intersection will be used for histone analysis. We 
have used data from all histone modifications globally, to create the union 
and the intersection sets, as exemplified in figure 12: 
Each experiment can have multiple samples and we know where each epigenetic 
marking occurs. Thus, we intend to study the context of these occurrences of epigenetic 
marking in these samples. Limiting the data will give us a picture of all positions 
(union) where a modification has already been found, while the intersection will only 
highlight the positions where all samples have a modification, i.e. those begging the 
showiest signal for modification.  
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   Location of an epigenetic mark. 
        X – Total of sample of each experiment. 
Figure 12: Histone union and histone intersection will be used for histone analysis. The fragments 
are pieces of DNA that can be there this epigenetic marking. 
 
3.3.2. Non-marked regions – Control  
All regions without epigenetic marking will be used as control, consisting of 43916 
fragments. The control context is represented by 19369407 nucleotides, has 5619417 A 
nucleotides; 5625109 T nucleotides; 4063926 C nucleotides; and 4060955 G 
nucleotides. 
This control was built to be able to compose the difference between marked and un-
marked regions, from the point of view of nucleotide contexts. 
 
3.3.3. Epigenomic regions features 
After obtaining the bed files about histone modifications, we calculating the union 
and intersection of data for each histone (table 4). We were able to obtain the number of 
fragments, either for the union or for the intersection. Then, we went to see the each size 
histone by the results of nucleotides each. Regarding the total number of epigenomes of 
each histone is present in Epigenomes Roadmap.  
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Histone 
modification 
Total number 
of epigenomes 
used 
Number of 
fragments of 
intersection 
Size of 
intersection 
Number of 
fragments 
of union 
Size of union 
H2AZ 9 
 
943538 87595468 3370563 5662528428 
H2AK5ac 14 
 
1099193 19392529 5118048 5203388932 
H2AK9ac 2 
 
7540982 
 
187681697 25196481 
 
1252156479 
H2BK5ac 14 
 
1367558 187681697 6108154 5168729322 
H2BK12ac 12 
 
756268 
 
15073138 5374386 4883438272 
H2BK15ac 12 
 
755162 43077505 2882531 
 
5271808939 
H2BK20ac 5 
 
2591040 250722582 5958391 
 
4684430742 
H2BK120ac 13 
 
119170 6646099 4010072 5035054959 
H3K4ac 13 
 
5125539 9765152 3870935 5075999683 
H3K4me1 219 
 
541 20425 263132 5641226891 
H3K4me2 15 
 
680423 36200326 2985055 5344793021 
H3K4me3 222 
 
35942 3657742 269427 
 
5640204628 
H3K9ac 92 
 
116596 
 
3090979 397897 5610818048 
H3K9me1 2 
 
5193073 
 
994475518 7398570 2800075700 
H3K9me3 222 
 
12220 570572 232374 5651302475 
H3K14ac 11 
 
1590559 38913268 4394035 4976720387 
H3K18ac 14 
 
572023 14272972 4851227 4885264835 
H3K23ac 13 
 
202129 
 
2554983 6304441 5085018511 
H3K23me2 4 
 
2514007 
 
86889503 9726522 4137734719 
H3K27ac 155 
 
16679 
 
1122336 305110 5629002434 
H3K27me3 220 
 
3303 150566 240131 5647724605 
H3K36me3 224 
 
5057 
 
159604 247963 5645795013 
H3K56ac 6 
 
704098 
 
55084013 6307120 4694914176 
H3K79me1 16 
 
524723 
 
8958925 5864587 
 
5149040554 
H3K79me2 9 
 
1499388 86792699 5036068 5080791287 
H3T11ph 1 
 
22475850 919530849 22475850 919530849 
H4K5ac 6 
 
1502077 4746029261 5592228 4746029261 
H4K8ac 14 
 
135657 3066909 5791131 4644321334 
H4K12ac 2 
 
4550850 913428784 6573836 2531942517 
H4K20me1 5 
 
665657 
 
59172393 7343572 4201096750 
H4K91ac 9 
 
748451 17829434 6418264 
 
4604027535 
Table 4: Overall analysis of the union and intersection for each histone modification, the columns 
present the total number of epigenomes, size of reunion, size of intersection and number of 
fragments. 
 
As would be expected, when there is only one epigenome the union and intersection 
will be the same (ex: H3T11ph). When we increase the number of epigenomes, we have 
greater union values composed to a smaller intersection (ex: H2AK9ac). 
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In relation to the chromosomes, we also made a global analysis getting the 
intersection, union and control (table 5). The size was obtained by nucleotides from all 
fragments present in each chromosome. 
 
 Global 
 Intersection Union Control 
Parameters 
Number of 
fragments 
Size 
Number of 
fragments 
Size 
Number of 
fragments 
Size 
Chr1 16 1989 14482 445209149 3759 2020432 
Chr10 4 131 10822 258749690 2965 1439029 
Chr11 0 0 5181 261238234 1005 311331 
Chr12 0 0 4508 260263443 832 180427 
Chr13 0 0 3159 190662634 571 139927 
Chr14 0 0 4099 175892351 867 173738 
Chr15 0 0 9615 159858419 2837 1302962 
Chr16 0 0 8086 155093837 2101 969623 
Chr17 0 0 4450 154057373 1088 574219 
Chr18 7 322 2618 148871408 522 120858 
Chr19 19 653 2403 110732367 601 338352 
Chr2 3 73 11226 474279089 2164 619698 
Chr20 0 0 1628 118751369 315 67217 
Chr21 0 0 1598 70001825 270 47194 
Chr22 0 0 3919 68904437 966 262435 
Chr3 0 0 6705 388557523 1264 262379 
Chr4 0 0 7730 373806895 1441 465539 
Chr5 0 0 10105 351525659 2473 1489023 
Chr6 2 180 6517 333579704 1285 354256 
Chr7 3 242 9429 308401930 2077 764556 
Chr8 0 0 7377 283606922 1770 769314 
Chr9 0 0 25186 230842567 7412 3461339 
ChrX 0 0 12853 298904834 2486 1147443 
ChrY 0 0 12594 40736769 2845 2088116 
Table 5: Global analysis showing the intersection, union and control, number of fragments and size. 
 
39 
 
As can be seen the intersection only has data for 7 chromosomes, unlike the union 
and control where all chromosomes are represented (24 chromosomes). Again, the 
number of fragments is smaller for the intersection forger for the union. 
 
3.4. Genomic context analysis 
3.4.1. Content C+G – Control vs Union 
One characteristic of DNA is its C+G content. The C+G content various greatly 
between organisms and within the gene. The of a single organism, especially among 
mammals. It is also know that the human genome has regions of high C+G content, 
alternating with regions of low C+G content. 
To move away the hypothesis that the C+G contents could to evaluate the 
association between C+G content and the occurrence of epigenetic marking, we applied 
the t-test to test if: 
H0: C+G content of average union= C+G content of average control  
H1: C+G content of average union≠ C+G content of average control 
 
We obtained the following results (table 6): 
 
t-test df p-value Cohen’s d 
7.33 229261 <0.001 0.039 
Table 6: T-test values and Cohen’s d. df matches degrees of freedom. p-value matches p-value 
 
Thus allowing to reject the H0 hypothesis. We also built a box plot (see figure 13), 
which is a graphical representation frequently used to compare multiple data sets. With 
this graph we can see how the data are distributed, namely, the highest or lowest 
concentrations, symmetry and occurrence of outlier values.  
For this representation, one begins by collecting 5 types of information from each 
sample: the two extremes (minimum and maximum), the median and the 1st and 3rd 
quartiles. Then, these values are plotted for each sample of values. 
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Figure 13: Boxplot of C+G content for control and union. The union has outliers, like the control. 
This means that market fragments are sometimes very rich in C and G, something that happen in 
un-market ones. 
 
As we can see in figure 13, the union set and the control set have many higher 
outliers and have some lower outliers. 
As mentioned, Cohen’s d is a measure of the force with which a phenomenon of 
interest occurs, serving that way in complement to the p-value. Here, we obtained the 
following result: d = 0.039. Thus, by classification of Cohen’s d, we conclude that the 
size effect of C+G content of our analysis is small. 
 
3.4.2. Global analysis of genome 
We compared the total of fragments of the global union with those of the control, to 
understand if the context of epigenetic marking is equal and thus there is no specificity 
for epigenetic marking at the level of DNA sequence. The same held for global 
intersection. To do this, we applied the chi-square test and the Cramer's V, for 
nucleotides, dinucleotides, trinucleotides and tetranucleotides (table 7). 
 
 Union vs Control Intersection vs Control 
Parameters X
2 
df p-value Cramer's V X
2 
df p-value Cramer's V 
Nucleotide 8969.3 3 * 0.0012 15.9 3 0.0012 0.0009 
Dinucleotide 29912 15 * 0.0022 202.47 15 * 0.0032 
Trinucleotide 54176 63 * 0.0030 645.48 63 * 0.0057 
Tetranucleotide 91899 255 * 0.0040 2208.8 255 * 0.0107 
Table 7: Chi-square test values for comparing the total of fragments of the global union with the 
control. X
2 
matches chi-square test; df matches degrees of freedom; p-value matches p-value; 
Cramer's V matches measure of association Cramer's V. * p-value is <0.001. 
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The hypotheses tested were: 
H0: The epigenetic marking context in marked regions is equal to context in control 
unmarked ones. 
H1: The epigenetic marking context in marked regions is not equal to context in 
control unmarked ones.  
 
Looking at table 7, we can see that the epigenetic marking contexts are not equal since 
we rejected the H0 hypothesis. From values of Cramer's V, we see that the union have a 
stronger heterogeneity effect. However, even with small values for the Cramer’s V we 
proceeded to the analysis of residual. 
Using the heatmap function of the R program to visualize the analysis of residual of 
values from table 7, we conducted heatmaps for nucleotides, dinucleotides, 
trinucleotides and tetranucleotides. However, we will only show the union (see in figure 
14) and the intersection (see in figure 15) for dinucleotides. The rest of non-neglectable 
heatmaps are in annex 8. 
 
 
 
Figure 14: Heatmap which corresponds to comparison for dinucleotides union. The preference for 
both types of fragments is opposite. 
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Figure 15: Heatmap which corresponds to comparison with the control for dinucleotides 
intersection. We can again see that the preference for both types of fragments is opposite. 
 
In both cases, marked and unmarked regions show preference for opposite contexts. 
However, in the case of union marked regions prefer the dinucleotides TA, while the 
control prefers CG. In the case of intersection marked regions prefer dinucleotide CC 
and unmarked ones TT. 
 
3.4.3. Global analysis of histones 
In order to test if the context of epigenetic marking is homogeneous among histone 
modifications. We applied the chi-square test and the Cramer's V for histone union and 
histone intersection again for nucleotides, dinucleotides, trinucleotides and 
tetranucleotides (table 8). 
 
 Histone union  Histone intersection 
Parameters X
2 df p-
value 
Cramer's V X2 df p-value Cramer's V 
Nucleotide 78802000 90 * 0.013 56302000 90 * 0.0466 
Dinucleotide 173030000 450 * 0.0089 132060000 450 * 0.0320 
Trinucleotide 255120000 1890 * 0.0076 200350000 1890 * 0.0280 
Tetranucleotide 335490000 7650 * 0.0087 335490000 7650 * 0.0087 
Table 8:Chi-square test value for the histone union and histone intersection of the 31 histone 
modifications. X
2
 matches chi-square test; df matches degrees of freedom; p-value matches p value; 
Cramer's V matches measure of association Cramer's V. *p-value is <0.001. 
 
Looking at the hypotheses of this test we have: 
H0: The epigenetic marking context is homogeneous among histone modifications. 
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H1: The epigenetic marking context is not homogeneous among histone 
modifications. 
 
Through the values obtained for the chi-square test, we concluded that epigenetic 
marking context is not homogeneous among histones, either for histone union or to the 
histone intersection. With regard to the values of Cramer’s V, there is a weak 
heterogeneity effect either the histone union or the histone intersection, but the histone 
intersection has a stronger heterogeneity effect. 
Despite the values of Cramer’s V being low, we also performed the residuals 
analysis. Although this was done for nucleotides, dinucleotides, trinucleotides and 
tetranucleotides, we only present the heatmap of the histone union (see in figure 16) and 
the histone intersection for single nucleotides (see in figure 17), because the remaining 
had the same profile. The remaining heatmaps are presented in annex 8.  
 
 
Figure 16: Heatmap of nucleotides histone union of all histone modifications. There are two histone 
modifications that stand out, the H4K12ac and H2AK9ac, which have preference for the 
nucleotides G and C. All other histones has a more homogeneous preference and show an 
environment in As and Ts. 
 
Through the analysis of figure 16, there are two histone modifications that show a 
different pattern in relation to the preference of the DNA nucleotide content, these being 
H4K12ac and H2AK9ac who have preference for nucleotides G and C. There were four 
clusters with homogeneous behaviors, one of which being, with preference for A and T 
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nucleotides, formed mainly by histone H3 modifications and methylations plus two 
acetylations and histone H2AZ. Another cluster consists of almost all histone H4 
modifications, having also three histone H3 modifications, with preference for G and C 
nucleotides. The third cluster is formed by H4K12ac and H2AK9ac and shows 
preference for nucleotides G and C. And the last cluster is formed by the remaining 
histone H3 and H2 modifications, mainly acetylation, and having preference for 
nucleotides G and C or T and A. Thus, we conclude that the groups may be formed by 
the type of histone (H2, H3 and H4), as well as by the type of modification (acetylation 
or methylation). In a more general form, we can see groups formed by transcription 
activating histone modifications (normally acetylations) while other groups include 
mainly modifications of histones that inactivate transcription (normally methylations). 
 
 
Figure 17: Heatmap of nucleotides histone intersection of all histone modifications. There are two 
histone modifications that stand out, the H4K5ac that has preference for the content of nucleotides 
A and T and H4K12ac that has preference for the content of nucleotides G and C. All other 
histones has a more homogeneous preference and show an environment in As and Ts. 
 
Relative to intersection, figure 17, we again have two histones that stand out in 
relation to the preference of the content, histone H4K5ac has preference for the content 
of nucleotides A and T; and histone H4K12ac has preference for the content of 
nucleotides G and C, as in the histone union dataset. All other histone had a more 
homogeneous behavior. Therefore, it is possible to identify a cluster formed only by 
H4K5ac; another one formed by H4K12ac; and a third cluster, which is subdivided into 
several sub-clusters formed by other histone modifications, most of which preferring G 
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and C rich contexts. Here it was not possible to identify groups by neither the type of 
histone nor the histone modification, like in the case of union. 
We can conclude for this analysis that histone modifications can be associated to 
specific contexts, enriched in either A and T or G and C. 
 
3.4.4. Chromosomes analysis 
In this analysis, we wanted to evaluate if the genomic context associated with the 
occurrence of epigenetic marking is homogeneous, among chromosomes. For this, we 
applied the chi-square test and the Cramer's V value (table 9), on the global union and 
global intersection datasets, for nucleotide, dinucleotide, trinucleotide and 
tetranucleotide contexts. 
 
 Global union  Control 
Parameters X2 df p-
value 
Cramer's 
V 
n X2 df p-
value 
Cramer's 
V 
n 
Nucleotide 10063000 69 * 0.0243 11325056856 57981 69 0.001 0.0315 38738814 
Dinucleotide 22290000 345 * 0.0161 11324685040 139530 345 * 0.0219 38651860 
Trinucleotide 34156000 1449 * 0.0161 11324313240 232510 1449 * 0.0228 38565276 
Tetranucleotide 46218000 5865 * 0.0188 11323941448 363210 5865 * 0.0286 38479184 
Table 9: Chi-square test to evaluate the homogeneity between epigenetic marking regions and non-
epigenetic marking regions for the global union datasets. X
2
 matches chi-square test; df matches 
degrees of freedom; p-value matches p-value; Cramer's V matches measure of association 
Cramer's V; n matches the sample size. *p-value is <0.001 
 
The test was conducted for the following hypotheses: 
H0: The nucleotide context having epigenetic marking is homogeneous among 
chromosomes. 
H1: The nucleotide context having epigenetic marking is not homogeneous among 
chromosomes.  
Through this test, we concluded that epigenetic marking is not homogenous among 
chromosomes. Regarding the Cramer's V value, the heterogeneity effect is weak in both 
global union and unmarked control, but the effect in the control showed a stronger 
heterogeneity effect than the global union. Although Cramer's V values are very low, 
there is indeed a significant but weak heterogeneity effect.  
Therefore, we performed a residual analysis to better understand where such small 
differences could be located. 
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Although not presented here, the same procedure was carried out for the global 
interception. However, that dataset was limited to only 7 chromosomes, yielding less 
relevant results. 
Therefore, we have built the heatmap with the residuals for the global union only 
(see in figure 18). We only show here the results for nucleotide contexts, while those for 
dinucleotides, trinucleotides and tetranucleotides are in annex 8. 
 
Figure 18: Heatmap of global union for single nucleotides. Three clusters were formed, two of 
which have a preference for the nucleotides A and T or G and C, and another cluster much more 
homogenous. 
 
Analysing the heatmap of figure 18, we can conclude that there are contexts 
identical profiles in the various chromosomes, showing preference for nucleotides A 
and T or C and G. There are 3 groups where there is homogeneity among chromosomes: 
one formed by chromosomes 19, 20, 16, 17 and 22 which have preference for 
nucleotides G and C; another formed by chromosomes 5, X, 3, 6, 13 and 4, with 
preference for nucleotides T and A; and, finally, another cluster formed by the 
remaining chromosomes that have a homogeneous preference for all nucleotides. Still 
other chromosomes showed isolate preference for nucleotides A and T or G and C. 
We conclude that different chromosomes have different preference for contexts 
enriched in either A and T or G and C. It also was possible to identify specific genomic 
contexts in some chromosomes through the heatmaps of trinucleotides (table 10): 
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Chromosome Identify specific genomic contexts in some chromosomes 
Chr3 
Chr4 
Chr5 
Chr6 
Chr13 
ChrX 
TAT and ATA 
Chr15 
Chr16 
Chr17 
Chr20 
Chr22 
GGG, CCC, GCC and GGC 
Chr19 GGG, CCC, GCC, GGC, CCG, CGG, GCG and CGC 
Table 10: Identify specific genomic contexts in some chromosomes. 
 
We carried out a more detailed analysis, with the intention of knowing which were 
the chromosomes that stand out relatively to the data for each histone modifications, 
i.e., to evaluate the homogeneity of each histone modifications, chromosome by 
chromosome. To do this, again we applied the chi-square test and the Cramer's V value to 
the global union dataset (table 11). 
 
Chromosome 
 
X
2 
Df p-value Cramer's V 
Chr1 Nucleotide 5541900 90 * 0.01258094 
 Dinucleotide 12210000 450 * 0.008355758 
 Trinucleotide 17976000 1890 * 0.007172909 
 Tetranucleotide 23507000 7650 * 0.008168113 
      
Chr10 Nucleotide 3174700 90 * 0.01251314 
 Dinucleotide 7016300 450 * 0.008323797 
 Trinucleotide 10358000 1890 * 0.00715518 
 Tetranucleotide 13605000 7650 * 0.008165683 
      
Chr11 Nucleotide 3715100 90 * 0.01347588 
 Dinucleotide 8161500 450 * 0.008937444 
 Trinucleotide 12022000 1890 * 0.0076742 
 Tetranucleotide 15773000 7650 * 0.008753228 
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Chr12 Nucleotide 3235000 90 * 0.01258799 
 Dinucleotide 7101900 450 * 0.008345724 
 Trinucleotide 10488000 1890 * 0.007175305 
 Tetranucleotide 13787000 7650 * 0.00819161 
      
Chr13 Nucleotide 3009100 90 * 0.01443056 
 Dinucleotide 6590500 450 * 0.009556667 
 Trinucleotide 9755500 1890 * 0.008226674 
 Tetranucleotide 12925000 7650 * 0.009419966 
      
Chr14 Nucleotide 2412200 90 * 0.01329056 
 Dinucleotide 5287000 450 * 0.00880438 
 Trinucleotide 7790400 1890 * 0.007561428 
 Tetranucleotide 10241000 7650 * 0.008631028 
      
Chr15 Nucleotide 1661400 90 * 0.01150411 
 Dinucleotide 3682000 450 * 0.007663108 
 Trinucleotide 5437600 1890 * 0.006588455 
 Tetranucleotide 7122800 7650 * 0.007508651 
      
Chr16 Nucleotide 1391600 90 * 0.01061339 
 Dinucleotide 3130200 450 * 0.007122217 
 Trinucleotide 4638200 1890 * 0.006133536 
 Tetranucleotide 6118800 7650 * 0.007019477 
      
Chr17 Nucleotide 1305500 90 * 0.01021069 
 Dinucleotide 2939600 450 * 0.006855525 
 Trinucleotide 4350500 1890 * 0.005900137 
 Tetranucleotide 5704200 7650 * 0.006733217 
      
Chr18 Nucleotide 2035600 90 * 0.01330172 
 Dinucleotide 4482200 450 * 0.008832395 
 Trinucleotide 6632000 1890 * 0.007601348 
 Tetranucleotide 8755600 7650 * 0.008693676 
      
Chr19 Nucleotide 760310 90 * 0.009184634 
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 Dinucleotide 1753800 450 * 0.006241502 
 Trinucleotide 2621000 1890 * 0.005397956 
 Tetranucleotide 3536500 7650 * 0.006251441 
      
Chr2 Nucleotide 6482600 90 * 0.01329926 
 Dinucleotide 14234000 450 * 0.008818181 
 Trinucleotide 21020000 1890 * 0.00758159 
 Tetranucleotide 27659000 7650 * 0.008656126 
      
Chr20 Nucleotide 1074300 90 * 0.01054775 
 Dinucleotide 2422900 450 * 0.007087515 
 Trinucleotide 3588100 1890 * 0.006101751 
 Tetranucleotide 4705200 7650 * 0.006965709 
      
Chr21 Nucleotide 1267000 90 * 0.01536944 
 Dinucleotide 2779500 450 * 0.01018642 
 Trinucleotide 4086200 1890 * 0.008738524 
 Tetranucleotide 5387900 7650 * 0.009987341 
      
Chr22 Nucleotide 400980 90 * 0.008454151 
 Dinucleotide 946190 450 * 0.005810546 
 Trinucleotide 1426000 1890 * 0.005046394 
 Tetranucleotide 1904400 7650 * 0.005813841 
      
Chr3 Nucleotide 5199900 90 * 0.01314445 
 Dinucleotide 11400000 450 * 0.008708961 
 Trinucleotide 16868000 1890 * 0.007495008 
 Tetranucleotide 22276000 7650 * 0.008573314 
      
Chr4 Nucleotide 5640000 90 * 0.01417404 
 Dinucleotide 12321000 450 * 0.00937503 
 Trinucleotide 18278000 1890 * 0.008079123 
 Tetranucleotide 24295000 7650 * 0.009263419 
      
Chr5 Nucleotide 4899400 90 * 0.01348501 
 Dinucleotide 10751000 450 * 0.008938925 
 Trinucleotide 15922000 1890 * 0.007696586 
50 
 
 Tetranucleotide 21071000 7650 * 0.008810834 
      
Chr6 Nucleotide 4500600 90 * 0.0132051 
 Dinucleotide 9860000 450 * 0.008746035 
 Trinucleotide 14584000 1890 * 0.007525744 
 Tetranucleotide 19220000 7650 * 0.008598862 
      
Chr7 Nucleotide 4114300 90 * 0.01317627 
 Dinucleotide 9023000 450 * 0.008731506 
 Trinucleotide 13299000 1890 * 0.007500061 
 Tetranucleotide 17470000 7650 * 0.00855484 
      
Chr8 Nucleotide 3760900 90 * 0.01309428 
 Dinucleotide 8268900 450 * 0.008688105 
 Trinucleotide 12231000 1890 * 0.007475839 
 Tetranucleotide 16117000 7650 * 0.008542491 
      
Chr9 Nucleotide 3111900 90 * 0.01331718 
 Dinucleotide 6836800 450 * 0.00883256 
 Trinucleotide 10065000 1890 * 0.007582296 
 Tetranucleotide 13252000 7650 * 0.00865695 
      
ChrX Nucleotide 4437700 90 * 0.01453681 
 Dinucleotide 9792200 450 * 0.009664377 
 Trinucleotide 14648000 1890 * 0.008364436 
 Tetranucleotide 19642000 7650 * 0.009605598 
      
ChrY Nucleotide 585460 90 * 0.01747597 
 Dinucleotide 1367000 450 * 0.01195572 
 Trinucleotide 2205700 1890 * 0.01075021 
 Tetranucleotide 3500200 7650 * 0.01326867 
Table 11: Chi-square test value for the global union chromosome by chromosome. X
2
 matches chi-
square test; df matches degrees of freedom; p-value matches p value; Cramer's V matches measure 
of association Cramer's V. *p-value is <0.001 
 
The hypotheses test was:  
H0: The epigenetic marking context is homogeneous among histones chromosome 
by chromosome. 
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H1: The epigenetic marking context is not homogeneous among histones 
chromosome by chromosome. 
 
From the test, we concluded that the epigenetic mark context is not homogeneous in any 
chromosome, thus rejecting the H0. 
As to the Cramer's V values, these are similar for all chromosomes, except for 
chromosome Y which has a higher heterogeneity effect. The respective analysis of 
residues, was conducted for all chromosomes, for nucleotides, dinucleotides, 
trinucleotides and tetranucleotides, but here we show only a few chromosomes, as an 
example, such as chromosome 1 for nucleotides (see in figure 19), that illustrates well 
what happened in general the remaining chromosomes. Again in this analysis, the 
chromosome Y is the exception (see in figure 22). 
 
 
Figure 19: Heatmap of global union for nucleotide context of chromosome 1. The chromosomes 
have an identical profile, highlighting H4K12ac H2AK9ac that has a preference for contexts 
enriched in G and C. The remaining histones have a more or less homogenous behavior. 
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Figure 20: Heatmap of global union for nucleotide contexts of chromosome 22. We can see again 
that the histones H4K12ac H2AK9ac that have a preference for contexts enriched in G and C. The 
remaining contents histones have a more or less homogeneous behavior. 
 
 
 
Figure 21: Heatmap of global union for nucleotide contexts of chromosome X. It shows that the 
histones H4K12ac H2AK9ac that have a preference for contexts enriched in G and C. The 
remaining contents histones have a more or less homogeneous behavior. 
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Figure 22: Heatmap of global union for nucleotide contexts of chromosome Y. Observed three 
groups where the content of the histones is homogeneous, one of them have preference for contexts 
enriched in A and T; another group have preference for contexts enriched in G and C; The third 
group have a homogeneous behavior. 
 
In general, all chromosomes have an identical profile (e.g. figures 19, 20 and 21), 
which highlights H4K12ac and H2AK9ac that have a preference for nucleotides G and 
C. It is possible to identify three relevant clusters, one formed by H4K12ac and 
H2AK9ac; another cluster that although having more homogeneous preference, show an 
overall preference for G and C; and third cluster that is also more homogeneous, but 
contains certain histone modifications with preference for A and T. 
As stated previously, there is one exception to this profile that corresponds to the 
chromosome Y, figure 22. Here we observed three clusters where the content of the 
modifications is homogeneous, one is formed by H3K4me3, H3K36me3, H3K9me3, 
H3K27me3, H3K4me1, H3K9me3, H3K27ac, H3K9ac and H2AZ, and have preference 
for A and T; another is formed by H4K8ac, H4K12ac, H3K14ac, H2BK5ac, H3K23ac, 
H2Bk12ac, H4K91ac and H3K18 ac, and shows are preference for nucleotides G and C; 
The third cluster is formed by the remaining histones, and has a homogeneous behavior. 
 
3.4.5. Analysis of different histone modifications 
 It was also our intention to understand in what epigenomes, the chromosomes 
are more different from each other. To this end, we apply the chi-square test and the 
measure of association Cramer's V for the histone union and histone intersection, see in 
annex 6. 
This analysis was done with the objective of responding to this test hypotheses: 
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H0: The epigenetic marking context is homogeneous among chromosomes for each 
histone modification. 
H1: The epigenetic marking context is not homogeneous among chromosomes for 
each histone modification. 
 
The results of this test and its values show in annex 6, reveals that the occurrence 
epigenetic marking is significantly heterogeneous among chromosomes. Regarding the 
values of Cramer's V, we can see that there is a greater association at the histone 
intersection level than the histone union of histones. 
To better understand the results for the histone union, the heatmap for nucleotides, 
dinucleotide, trinucleotide and tetranucleotides for all histone modifications was built. 
However, we show only one example to illustrate the common trend of in this analysis 
(see in figure 23). In relation to histone intersection, we show several examples, as not 
all histones had the same profile (see in figures 24, 25, 26 and 27).  
 
 
Figure 23: Heatmap of H2AK5ac nucleotide preference, using the histone union dataset. There are 
five groups in which the content of chromosomes is homogeneous: two groups, although separated, 
have preference for nucleotides G and C; two groups, also separated, have preference for 
nucleotides A and T; and one more group has a homogenous behavior. 
 
The heatmap in figure 23 features three clusters in which the content of 
chromosomes is homogeneous: one of them is formed by chromosomes 9, 10, 11, 15, 1, 
19, 20, 16, 17 and 22, and have preference for nucleotides G and C; another one is 
formed by chromosomes 5, 3, 6, 13, 8, 18, 2, X and 4 which prefer nucleotides A and T; 
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and, finally, another cluster that homogenous behavior. Also chromosomes 19 and 4 
exhibited a globally different behavior in comparison to others. 
 
 
 
Figure 24: Heatmap of H2AZ nucleotide preference, using the histone intersection datasets. There 
are three clusters: one that prefers nucleotides G and C; another that prefers nucleotides A and T; 
and a last one that shows a homogeneous behavior. 
 
 
Figure 25: Heatmap of H2BK5ac nucleotide preference, using the histone intersection datasets. 
There are two cluster homogeneous, one of which has preferably at the content of the nucleotides A 
and T; and another which has a preference for the homogeneous content. 
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Figure 26: Heatmap of H2BK20ac nucleotide preference, using the histone intersection datasets. 
There are two clusters: one of which prefers nucleotides G and C; other that prefers nucleotides A 
and T. 
 
 
Figure 27: Heatmap of H4K5ac nucleotide preference, using the histone intersection datasets. We 
can see three clusters: one of which prefers nucleotides G and C; another that prefers nucleotides A 
and T; and a last one that shows a homogeneous behavior.  
 
The epigenetic marking context is not homogeneous among chromosomes for each 
histone modification, as already seen in annex 6, and these heatmaps can confirm those 
values.  
In heatmap of figure 24 relative to H2AZ, shows three clusters that present 
homogeneity: one formed by chromosomes 19, 17, 22 and 16 having preference for 
nucleotides G and C; another formed by chromosomes 4, Y, 12, 3, 18, 8, 10, 5, 2, 6 and 
13 having preference for nucleotides A and T; and a last cluster formed by the 
remaining chromosomes that did not show a marked preference by any nucleotide. 
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Figure 25 shows the heatmap of H2BK5ac, where only two clusters are 
homogeneous, one of which shows preference for nucleotides A and T, formed by 
chromosomes Y, 8 and 10; and another one formed by the remaining chromosomes, 
with no marked preference. 
As to H2BK20ac, figure 26, two clusters were formed: one formed by 
chromosomes 17, 16, 22 and 19, with preference for nucleotides G and C; another one 
formed by the remaining chromosomes, with preference for nucleotides A and T. 
One last example that proves that the marking epigenetic context is not 
homogeneous among chromosomes when each histone modification is considered is the 
case of H4K5ac (see in figure 27). We can identify three clusters: one of which is 
formed by chromosomes 19, 20, 16, 17, 22, 11, 10, 9, 1 and 15 which prefers 
nucleotides G and C; another cluster formed by the chromosomes 5, 3, 13, X, 6, 18, 8, 2 
and 4 that has preference for nucleotides A and T; and finally a cluster formed by the 
remaining chromosomes with no major a preference for any nucleotide context. 
 
Another analysis was performed in order to verify of the epigenetic marking 
context for each histone modification was equal to the unmarked control sequences. To 
this end, again we applied the chi-square test and the Cramer's V for nucleotides, 
dinucleotides, trinucleotides and tetranucleotides (see annex 7). 
The hypotheses tested this time were: 
H0: The epigenetic marking context for each histone is equal to the epigenetic 
marking context for control sequences. 
H1: The epigenetic marking context for each histone is not equal to the epigenetic 
marking context for control sequences.  
 
Through this test we were able to conclude in favour of H1, which suggest that 
specific contexts somehow originate specific histone modification.  
Despite the values of Cramer’s V being low, we still performed the analysis of 
residues. However, most of the results can be considered negligible. We will just show 
some corresponding to the strongest Cramer's V (see in figures 28, 29 and 30). 
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Figure 28: Heatmap for H2AZ at the level of nucleotides. This modification has preference for Ts. 
 
 
 
Figure 29: Heatmap for H2AK9ac at the level of dinucleotides. There is a preference for the TT, 
AA, AT and TA contexts. 
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Figure 30: Heatmap for H3T11ph at the level of trinucleotides. There is a preference for TAA 
contents. 
 
As we can see in the heatmap of figure 28, for H2AZ, there was a preference for T 
and A, while the control had preference for C and G. Meaning, that fragments enriched 
in T and A, had a higher tending to have. 
In relation to H2AK9ac (see in figure 29) there’s a preference for TT, AA, AT and 
TA, while the control had preference for GC, GG and CC. 
As to H3T11ph, figure 30, we see a preference for the trinucleotide GCT. In the 
control the preference is for TTT, TAT, AAA, ATA and AAT. 
 
What can we conclude from the above heatmaps is that each modifications its own 
preference. Therefore, it becomes possible to identify specific genomic contexts in 
histone modifications (table 12): 
 
Histone modifications Identify specific genomic contexts  
H2AZ 
H2AK5ac 
 H2BK5ac 
H2Bk15ac 
H3K4ac 
H3K4me1 
H3K4me2 
K3K4me3 
H3K9ac 
TTA and TAA 
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H3K9me3 
H3K23ac 
H3K27ac 
H3K27me3 
H3K36me3 
H3K79me1  
H3K79me2 
H2AK9ac GGG, GCC and GGC 
H2BK12ac 
H2BK20ac  
H3K14ac  
H3K18ac  
H3K56ac  
H4K12ac 
GCT and CTC 
H2BK120ac TTA, TAA, CTC and GCT 
H3K9me1 AGG, GCT, CTG and CCT 
H3K23me2 AGG, CTC and GCT 
H3T11ph GCT 
H4K5ac GCT, CTC and TTA 
H4K12ac GGG, GGC, CCC, GCC and GAG 
H4K20me1 CAG, CAC, AGG, CTC, GCT and 
CCT 
H4K91ac GCT, CTT and AGG 
Table 12: Identify specific genomic contexts in histone modifications. 
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4. Discussion 
The type of work presented here is a pilot study. That is, a test small, of procedures, 
materials and methods proposed for a given search.  
Throughout this dissertation we presented results obtained from the application of 
various statistical methodologies to the study of the human genome. The main objective 
was to study the epigenetic signals of the human genome, which can identify motifs for 
each histone modification. Thus, understanding the relationship between DNA 
sequences and the occurrence of epigenetic marking. 
In this study the following methods were used: 
 Contingency tables analysis; 
 Measure of association Cramer’s V; 
 Heatmaps; 
 Dendograms. 
Through contingency tables, we used statistical chi-square test, to reject the 
hypothesis of independence between the DNA content and the occurrence of epigenetic 
marking and we obtained small amounts of association. In conclusion, there is 
dependence between the content and the occurrence of epigenetic marking. 
Through heatmaps, we could identify specific genomic contexts for each histone 
modification. One of the strongest contexts is that TTA and TAA trinucleotides are 
present mainly in regions of H2 and H3 histone modification, for both acetylation and 
methylation. However, there are other histone modifications that have other enriched 
motifs, as shown in the results. So, with this analysis, it was possible to predict the 
occurrence of a modification from the nucleotide of the region context. 
The histone modifications that showed highest differences between chromosomes 
histones were H4K12ac and H2AK9ac. H4K12ac is related to memory in its 
consolidation (annex 4) since there is evidence that the epigenome regulates the 
consolidation of information processed in long-term memory. In relation to H2AK9ac, 
which is also changed in most chromosomes, in addition to other histone modifications 
changed, , such as H4K8ac,  in the chromosome Y (which is the least homogeneous 
chromosome), they are all connected to the activation / inactivation of the transcription 
(annex 4). As mentioned earlier, epigenetic mechanisms, such as DNA methylation, 
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histone modifications and ncRNAs, pattern the activation / inactivation of genes being 
powerful regulators of gene activity, RNA transcription and protein homeostasis. 
Therefore, one would expect that certain histone were changed more than others. 
Through the dendrogram analysis, it was possible to create groups by the type of 
histones (H2, H3 and H4) and the type of modification (acetylation or methylation) 
based on the samples behavior. Interestingly, this separates groups including 
transcription-activating histone modifications (normally acetylations) and transcription-
inactivating owes (normally methylation). 
We only analyze nucleotide, dinucleotide, trinucleotide and tetranucleotide 
contexts, the latter being the most informative context to take conclusions because it is 
the word size of nucleotides is greater. From the results, we can say that increasing the 
word size of contexts, more information and conclusions could be drawn. The word size 
of nucleotides was a limitation of this analysis. 
 
4.1. Future work 
According to the results, it will be interesting to do the following future work:  
 In terms of genomic location, to evaluate interactions among epigenomes 
and motifs position in the fragment;  
 To performed this analysis increasing the word size of contexts, and thus 
relating with to specific genomic contexts in histone modification and in 
chromosomes; 
 To study the effect of variables present in the metadata, such as age, sex, 
anatomy, epigenome class, ethnicity and solid/liquid status; 
 The results now obtained with this information about the expression of 
genes, to select the relevant set points and study them separately. 
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Annex 1 – Modifications of histones 
As mentioned in the introduction, there is a wide array of known histone 
modifications, including acetylation, methylation, phosphorylation and ubiquitylation. 
These modifications are added to and/or removed from histone proteins by diverse 
families of proteins including histone acetyltransferases/deacetylases, histone 
methyltransferases/demethylases, histone kinases/phosphatases, and ubiquitin ligases. 
Below is described a little about each modification:  
 Histone Acetylation 
Histone acetylation is a dynamic process. Histone acetyltransferases and histone 
deacetylases are the enzymes that are responsible for the addition and removal of this 
modification, and which target particular lysine residues (51). 
One of the more heavily studied histone deacetylases is Sir2, a NAD dependant 
histone deacetylase. It has been shown to be important for the maintenance of silent 
chromatin and has been implicated as a major regulator of cell aging (51). 
 Histone Methylation 
One of the most well characterized histone modifications is histone methylation, in 
addition histones can be methylated on both lysine and arginine residues.  
Unlike histone acetylation, histone methylation does not affect the charge of the 
modified amino acid. In addition, each lysine is able to accept up to three methyl 
groups, resulting in mono-, di-, and trimethylated lysine forms (52). In many cases, each 
of these methyl-lysine forms are detectable in the cell at any given time, and have 
distinct localization patterns, suggesting that each modified form of lysine has a distinct 
biological role (51–53). 
Furthermore, unlike histone acetylation, in which the presence or absence of the 
modification contributes to an epigenetic state, the location of the methyl mark on the 
histone dictates its function. 
The main family of enzymes that catalyse histone lysine methylation contain the 
conserved SET domain. Misregulation of these proteins, through overexpression, 
deletion or chromosomal translocations has been implicated in many types of human 
cancers. 
 Histone Ubiquitination 
Ubiquitin is a protein moiety, which is covalently attached to a protein through a 
series of enzymatic steps (Fig. 31) (54,55).  
74 
 
There is Polyubiquitination, or the addition of multiple ubiquitin moieties, which is 
typically a sign of protein degradation that is mediated by the proteosome (54,55).  
There is also monoubiquitination, or the addition of only a single ubiquitin, which 
has been observed on histones H2A and H2B (Fig. 32) and is thought to play a role in 
signalling (56–59). One mechanism by which monoubiquitylation of histones is thought 
to exert its effects, is by serving as “wedge” which can open up or disrupt chromatin 
structure (60).  
Furthermore, ubiquitylation of histones is reversible, as ubiquitin proteases that can 
remove this modification have been identified (58). However, the mechanism by which 
histone ubiquitylation contributes to epigenetic regulation is still unclear. 
 
 
Figure 31: Ubiquitin-conjugating pathway. Ubiquitin is activated by a ubiquitin-activating enzyme 
(E1) and then transferred to one of the many different ubiquitin-conjugating enzymes 
(E2).Ubiquitin is conjugated to the correct substrate through the intermediary of a large family of 
ubiquitin ligases (E3), which bind both the E2-ub complex and substrate. For simplicity, a RING 
domain E3 is shown. Proteins can be monoubiquitylated, whereby a single ubiquitin is attached, or 
polyubiquitylated, in which multiple ubiquitin moieties are attached to each other. Adapted image 
(57). 
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Figure 32: Ubiquitin ligases and deubiquitinating enzymes responsible for monoubiquitination of 
histones H2A and H2B. Major post-transcriptional modifications on histone H3 and H4 tails are 
also shown. Ac, acetylation; Me, methylation; P, phosphorylation. Adapted image (61). 
 
 Histone Phosphorylation 
Phosphorylation of histone proteins is another post-translational modification that 
has been studied (17,23). Histone phosphorylation has been linked to a variety of 
cellular processes, such as chromosome condensation and segregation, activation of 
transcription, gene silencing, apoptosis and DNA damage repair. Phosphorylation can 
serve as an activating signal on a target protein, as a transcription factor, to stimulate a 
response to the external signal resulting in the up- or downregulation of specific genes 
(62). 
We have the example of phosphorylation on histone H3 that has been specifically 
implicated in cell cycle progression and regulation of gene expression. In addition, 
phosphorylation of histone proteins may alter chromatin structure by affecting the 
charge of the histone proteins (63). 
A study on phosphorylation of histone H3, observed that, even though 
phosphorylation of certain histone H3 residues appears to have been conserved, their 
functional significance might differ among eukaryotes, in particular between metazoan 
and plants. It was observed that, in mammalian cells, histone H3 is phosphorylated at 
several sites during mitosis, including serines 10 and 28 (H3S10ph and H3S28ph) and 
threonines 3 and 11 (H3T3ph and H3T11ph) (20).  
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Annex 2 – The Three main categories of small ncRNAs 
 
There are three main categories: 
a) Short interfering RNAs (siRNA) 
siRNAs is the most broadly distributed in both phylogenetic and physiological 
terms and are characterized by the double-stranded nature of their precursors, such as 
miRNAs (21,64). 
b) MicroRNAs (miRNA) 
miRNAs are another class of small RNAs that play a role in gene regulation, which 
control gene expression acting post-transcriptionally by destabilization or translational 
repression of the mRNA, inhibiting protein synthesis (22,64). Like as siRNAs, these are 
also broadly distributed in both phylogenetic and physiological terms and are 
characterized by the double-stranded nature of their precursors (21,64). 
The degree of complementarity between the miRNA and the target mRNA can 
dictate whether the target mRNA is degraded or translationally blocked. Strong pairing 
with the mRNA target stimulates cleavage by endonuclease, while weaker pairing can 
interfere with translation and direct degradation of mRNA. So, varying 
complementarity means that a particular miRNA has the potential to affect multiple 
targets (21,22). Presently, it is known that miRNAs can behave as oncogenes and 
tumour suppressor genes because it has been observed that certain miRNAs are 
upregulated in certain tumour types, and others play critical roles in cell cycle 
progression (65). 
c) Piwi interacting RNAs (piRNA) 
The third class of small RNAs is called piRNAs and unlike the siRNA and miRNA,  
these are primarily found in animals, exert their functions most clearly in the germline, 
and derive from precursors which, while being poorly understood, appear to be single 
stranded (21,22). 
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Annex 3 – The various tissues present in Consortium 
 
Cell Type Description 
Adrenal – Fetal 
 Fetal, Adrenal Gland 
 
 
“The fetal adrenal gland, during most of 
time the gestation, is almost exclusively 
dedicated to the production of 
dehydroepiandrosterone sulfate (DHEA-
S)”. This specialized ability is unique to 
primates and occurs because of a 
specialized fetal zone that composes the 
bulk of the fetal adrenal gland. The most 
of the steroid released by the fetal zone is 
DHEA-S, which is used by the placenta to 
produce estrogens (66,67). 
Brain 
 Brain Anterior Caudate  
 Brain Cingulate Gyrus  
 Brain Hippocampus Middle  
 Brain Angular Gyrus  
 Brain Inferior Temporal Lobe 
 Brain Germinal Matrix  
 Brain Mid Frontal Lobe  
 Brain Substantia Nigra  
 Neurosphere Cultured Cells Cortex 
Derived  
 Neurosphere Cultured Cells 
Ganglionic Eminence Derived
  
 Brain Cerebellum 
The brain is composed of many 
specialized areas that work together: 
cerebellum is at the base and the back of 
the brain; basal ganglia are a cluster of 
structures in the centre of the brain; brain 
stem is between the spinal cord and the 
rest of the brain; and cortex is the 
outermost layer of brain cells (68,69). 
The brain is also divided into many lobes: 
frontal lobes; parietal lobes; temporal 
lobes; occipital lobes (69). 
The brain is surrounded by a layer of 
tissue called the meninges (69). 
Brain – Fetal 
 Fetal, Brain  
 Fetal Spinal Cord 
One of the very first systems to develop is 
fetal nervous system, brain and spinal cord 
(69). 
Breast  The breast is the tissue overlying the chest 
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 Breast Stem Cells  
 Breast Myoepithelial Cells  
 Breast Luminal Epithelial Cells
  
 Breast vHMEC 
(pectoral) muscles. Women's breasts are 
constituted of specialized tissue that 
produces milk (glandular tissue) and still, 
fatty tissue (69). “The milk-producing part 
of the breast is organized into 15 to 20 
sections, named lobes. Within each lobe 
are smaller structures, called lobules, 
where milk is produced. The milk travels 
through a network of tiny tubes, the ducts, 
these connect and come together into 
larger ducts, which eventually exit the skin 
in the nipple. The dark area of skin 
surrounding the nipple is called the areola” 
(69). 
In addition, the breast is also constituted 
by connective tissue and ligaments provide 
support to the breast and give it its shape; 
nerves provide sensation to the breast; 
blood vessels, lymph vessels, and lymph 
nodes (69). 
ES Cells 
 H1  
 H9  
 HUES1  
 HUES3  
 HUES6  
 HUES8  
 HUES9  
 HUES13  
 HUES28  
 HUES44  
 HUES45  
 HUES48  
The Stem Cells are characterized by the 
capacity for self- renewal and the ability to 
differentiate into diverse specialized cell 
types, such as embryonic stem cells, 
Cancer Stem Cells and Induced 
Pluripotent Stem cells (IPSCs) (70). 
Stem cells are the only cells capable of 
undergoing self-renewal divisions,  these 
divisions are asymmetric in which a stem 
cell is able to produce an exact copy of 
itself as well as a daughter cell that 
undergoes differentiation into the lineages 
found in differentiated tissues. During 
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 HUES49  
 HUES53  
 HUES62  
 HUES63  
 HUES64  
 HUES65  
 HUES66  
 ES-I3 Cell Line  
 ES-WA7 Cell Line  
 UCSF-4Star 
stem cell expansion and tumorigenesis, 
stem cells may undergo symmetric 
divisions in which stem cells produce two 
different cell populations, one population 
retains the self-renewing properties of the 
parental cancer stem cell and the other 
population is tumor cell with ability to 
differentiate but without the ability to 
initiate tumor growth (71). 
ES – Derived Cells 
 H1 Derived Embryoid Body 
Cultured Cells  
 H9 Derived Embryoid Body 
Cultured Cells  
 HUES1 Derived Embryoid Body 
Cultured Cells  
 HUES3 Derived Embryoid Body 
Cultured Cells  
 HUES6 Derived Embryoid Body 
Cultured Cells  
 HUES45 Derived Embryoid Body 
Cultured Cells  
 H1 Derived Neuronal Progenitor 
Cultured Cells  
 H9 Derived Neuronal Progenitor 
Cultured Cells  
 H9 Derived Neuron Cultured Cells
  
 H1-BMP4  
 hESH1 derived mesenchymal  
 hESH1 derived mesendoderm 
 hESC Derived CD184+ Endoderm 
The Stem Cells derived from other cells, 
such as embryoid body cultured cells, 
neuronal progenitor cultured cells, neuron 
cultured cells, mesenchymal, 
mesendoderm, CD184+ endoderm 
cultured cells , CD56+ mesoderm and 
CD56+ ectoderm cultured cells. 
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Cultured Cells  
 hESC Derived CD56+ Mesoderm
  
 hESC Derived CD56+ Ectoderm 
Cultured Cells 
Exocrine – Endocrine 
 Adrenal Gland 
 Pancreas  
 Spleen  
 Thymus 
The endocrine gland is that secretes its 
hormones directly into the bloodstream 
from where it is transported to the target 
cells, tissues or organs to bring about its 
effects. However, the exocrine gland is 
that secretes its hormones into a system of 
ducts that lead to the external environment 
(68,69). 
Fat – Adult 
 Mesenchymal Stem Cell Derived 
Adipocyte Cultured Cells  
 Adipose Nuclei  
 Adipose Derived Mesenchymal 
Stem Cell Cultured Cells  
 Adipose Tissue 
“Mesenchymal stem cells have an intrinsic 
capacity to differentiate into various cell 
types in culture or after transplantation”. 
“Adipose cell are connective-tissue cell 
specialized to synthesize and contain large 
globules of fat. There are two types of 
adipose cells: white adipose cells contain 
large fat droplets, only a small amount of 
cytoplasm, and flattened, noncentrally 
located nuclei; and brown adipose cells 
contain fat droplets of differing size, a 
large amount of cytoplasm, numerous 
mitochondria, and round, centrally located 
nuclei” (68). 
GI – Adult 
 Liver, Adult  
 Stomach Smooth Muscle  
 Duodenum Mucosa  
 Duodenum Smooth Muscle  
 Pancreatic Islets  
The digestive tract is divided into upper 
gastrointestinal tract (mouth, throat, 
esophagus and stomach) and lower 
gastrointestinal tract (small intestine - 
duodenum, jejunum and ileum, and large 
intestine - cecum, colon, sigmoid colon, 
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 Colonic Mucosa  
 Rectal Mucosa 
 Rectal Smooth Muscle  
 Colon Smooth Muscle  
 Esophagus  
 Gastric  
 Sigmoid Colon  
 Small Intestine 
rectum and anus) (68,69). 
GI – Fetal 
 Fetal, Intestine Large  
 Fetal, Intestine Small  
 Fetal, Stomach 
The gastrointestinal tract arises initially 
during the process of gastrulation from 
the endoderm of the trilaminar embryo 
(week 3) and extends from 
the buccopharyngeal membrane to 
the cloacal membrane. The tract and 
associated organs later have contributions 
from all the germ cell layers (68,69). 
GU – Adult 
 Kidney, Adult  
 Bladder 
Urogenital system or also called 
genitourinary system, are the organs 
involved in reproduction and urinary 
excretion. Although their functions are 
independent, the structures involved in the 
excretion and reproduction are 
morphologically related (68). Thus, the 
main structures of the urinary system are 
the kidneys, ureters, bladder and urethra; 
and the main structures of the reproductive 
system are the testicles, the vas deferens, 
urethra and penis in men's case; and are 
the ovaries, fallopian tubes, uterus and 
vagina in the female case (68,69). 
Heart – Adult 
 Aorta  
 Heart  
“The heart is a muscular organ, located 
just behind and slightly left of the 
breastbone. The heart pumps blood 
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 Left Ventricle  
 Right Atrium  
 Right Ventricle 
through the network of arteries and veins 
called the cardiovascular system” (69). 
“The heart has four chambers: right atrium 
receives blood from the veins and pumps it 
to the right ventricle; right ventricle 
receives blood from the right atrium and 
pumps it to the lungs, where it is loaded 
with oxygen; left atrium receives 
oxygenated blood from the lungs and 
pumps it to the left ventricle; and left 
ventricle pumps oxygen-rich blood to the 
rest of the body. The left ventricle’s 
vigorous contractions create our blood 
pressure” (68,69). 
The coronary arteries run along the surface 
of the heart and provide oxygen-rich blood 
to the heart muscle. A web of nerve tissue 
also runs through the heart, conducting the 
complex signals that govern contraction 
and relaxation (68). Surrounding the heart 
is a sac called the pericardium (68). 
Heart – Fetal 
 Fetal, Heart 
The cardiovascular system is the first to 
operate in the embryo, mainly due to the 
need for an efficient method of oxygen 
and nutrient uptake. 
The primitive heart is composed of venous 
sinus, sinoatrial valve, primitive atrium, 
primitive ventricle, bulbus and truncus 
arteriosus, and between the middle of the 
4th week and the end of the 5th week of 
pregnancy occurs septation of the 
primitive heart (68,69). That is, the 
septation of the atrioventricular canal. 
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Hematopoietic Stem  
 CD34, Primary Cells  
 CD34, Mobilized Primary Cells
  
 CD34, Cultured Cells 
“The stem cells that form blood and 
immune cells are known as hematopoietic 
stem cells. These are ultimately 
responsible for the constant renewal of 
blood—the production of billions of new 
blood cells each day”. So, hematopoietic 
stem cell is a cell isolated from the blood 
or bone marrow that can renew itself, can 
differentiate to a variety of specialized 
cells, can mobilize out of the bone marrow 
into circulating blood, and can undergo 
programmed cell death, called apoptosis—
a process by which cells that are 
detrimental or unneeded self-destruct (72). 
IPs Cells  
 iPS 4.7  
 iPS 6.9  
 iPS-11a  
 iPS-11b  
 iPS-11c  
 iPS-15b  
 iPS-17a  
 iPS-17b  
 iPS-18a  
 iPS-18b  
 iPS-18c  
 iPS-19.7  
 iPS-19.11  
 iPS-20b  
 iPS-27b  
 iPS-27e 
“ IPSCs are adult cells that have been 
genetically reprogrammed to an 
embryonic stem cell–like state by being 
forced to express genes and factors 
important for maintaining the defining 
properties of embryonic stem cells” 
(73,74). IPSCs demonstrate important 
characteristics of pluripotent stem cells, 
including expressing stem cell markers, 
forming tumours containing cells from all 
three germ layers, and being able to 
contribute to many different tissues when 
injected into mouse embryos at a very 
early stage in development, and still 
express stem cell markers and are capable 
of generating cells characteristic of all 
three germ layers (73,74). 
These cells are already useful tools for 
drug development and modelling of 
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diseases, and scientists hope to use them in 
transplantation medicine (73,74). 
Kidney – Fetal 
 Fetal, Kidney  
 Fetal, Kidney Left  
 Fetal, Kidney Right  
 Fetal, Renal Cortex  
 Fetal, Renal Cortex Left  
 Fetal, Renal Cortex Right  
 Fetal, Renal Pelvis  
 Fetal, Renal Pelvis Left  
 Fetal, Renal Pelvis Right 
Kidney is the main organ of the urinary 
tract. It is a kind of factory to eliminate 
blood unnecessary or harmful substances, 
while losing the substances that are 
important for the functioning of the body, 
where the glomeruli (68,69). These 
glomeruli filter water and various 
substances. 
Lung – Adult 
 Lung 
The lung is part of the respiratory system, 
which is an expert system for the exchange 
of gases. Its main function is to oxygenate 
the blood and remove carbon dioxide or 
carbon dioxide from the body. The human 
being has two lungs located in the chest 
cavity, covered by a protective membrane 
known as the pleura. Each lung is divided 
into lobes, the right lung is larger and has 
three lobes; the left has only two (69,75).  
Lung – Fetal 
 Fetal, Lung  
 Fetal, Lung Left  
 Fetal, Lung Right  
 Fetal, Lung Fibroblast (IMR90) 
The development of the fetal lung is done 
in four stages, ranging from five weeks of 
pregnancy to early childhood, school age. 
The first step corresponds to the processes 
pseudoglandular period and from 5 to 16 
weeks of gestation. After this period, only 
the structures involved in gas exchange 
will not be formed. Fetal breathing is not 
yet possible. The second stage corresponds 
to the canalicular period, and occurs 
between 16 and 24 weeks of gestation. At 
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the end of this step the structures 
responsible for gas exchange, although 
immature, are already formed. Breathing is 
already possible, although limited. The 
third stage corresponds to the vesicular 
period and takes place from 24 weeks 
gestation until birth. The fourth stage 
corresponds to the alveolar period, and 
occurs from birth to school age (69,75). 
Muscle -  Adult 
 Skeletal Muscle  
 Muscle Satellite Cultured Cells
  
 Psoas Muscle 
Our walking ability depends on the 
combined action of bones, joints and 
muscle, under the regulation of the 
nervous system. 
The muscular system is formed by the 
body of the set of muscles, and we have 
big muscles such as the thigh, and small 
muscles, such as certain muscles of the 
face. They may be rounded (the orbicular 
eye, for example); plans (the skull, etc.); 
or spindle (like arms). In general, there are 
three types of muscles: non-striated 
muscle (smooth muscle); Skeletal muscle; 
Cardiac striated muscle (68,69). 
Muscle -  Fetal 
 Fetal, Muscle Arm  
 Fetal, Muscle Back  
 Fetal, Muscle Leg  
 Fetal, Muscle Lower Limb  
 Fetal, Muscle Upper Limb  
 Fetal, Muscle Trunk  
 Fetal, Muscle Upper Trunk 
The Muscular System develops from 
mesoderm except the iris muscles, which 
originates from neuroectoderma. Since the 
myoblasts, embryonic muscle cells, 
mesenchymal stem (embryonic connective 
tissue) (68,69). 
Placenta – Fetal 
 Fetal, Placenta  
The placenta is an organ that exists only 
during pregnancy and has several 
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 Placenta Amnion  
 Placenta Basal Plate  
 Placenta Chorion Smooth  
 Placenta Trophoblast Primary 
Cells  
 Placenta Villi 
functions such as: Provide nutrients and 
oxygen to the baby; Production of 
hormones; Baby immune protection; Baby 
impact protection in the womb; It also 
eliminates the waste that the baby 
produces, such as urine (68,69). 
Reproductive – Adult 
 Ovary  
 Testis Spermatozoa Primary Cells 
There is the female reproductive system 
constituted by the ovaries, fallopian tubes, 
uterus and vagina; and the male 
reproductive system constituted by the 
scrotum, testicles, epididymis, vas 
deferens, urethra, seminal vesicles, 
prostate and penis (68,69). 
Reproductive – Fetal 
 Fetal Ovary 
The ovary makes part of the female 
reproductive system (68). 
Skin – Fetal 
 Fibroblasts Fetal Skin Abdomen
  
 Fibroblasts Fetal Skin Biceps Left
  
 Fibroblasts Fetal Skin Biceps 
Right  
 Fibroblasts Fetal Skin Quadriceps 
Left  
 Fibroblasts Fetal Skin Quadriceps 
Right  
 Fibroblasts Fetal Skin Upper Back
  
 Fibroblasts Fetal Skin Upper Back 
The skin is the body that involves the body 
determining their limit with the external 
environment and performs various 
functions, such as thermal regulation, 
organic defense, blood flow control, 
protection against various agents of the 
environment and sensory functions (heat, 
cold, pressure, pain and touch). It is 
composed of three layers: epidermis, 
dermis and hypodermis, the outermost to 
the deepest, respectively (76). 
Spleen – Fetal 
 Fetal, Spleen  
 Fibroblasts Fetal Skin Back 
“In the fetus, the spleen acts as a 
hemopoietic center until late in gestation, 
and produces lymphocytes and monocytes 
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throughout life. The spleen arises as an 
aggregation of reticular mesenchymal cells 
in the dorsal mesentery of the stomach 
during the sixth to seventh weeks, 
menstrual age. It acquires it is 
characteristic crescent shape early in the 
fetal period” (69). 
Stromal – Connective 
 Bone Marrow Derived 
Mesenchymal Stem Cell Cultured 
Cells  
 Chondrocytes from Bone Marrow 
Derived Mesenchymal Stem Cell 
Cultured Cells  
 Primary Fibroblast  
 Fetal Skin  
 Foreskin Fibroblast Primary Cells
  
 Foreskin Keratinocyte Primary 
Cells  
 Foreskin Melanocyte Primary 
Cells  
 Breast Fibroblast Primary Cells 
Connective Tissue Proper is a group of 
connective tissues designed generally to 
bind parenchymal tissues, blood vessels 
and nerves together to form organs and to 
passively transfer mechanical tension from 
point to point within the organ or within 
the animal body.  The stromal connective 
tissues belong to this group, that are the 
common connective tissues found in the 
stroma, namely loose connective tissue 
and dense irregular connective tissue (76). 
Thymus – Fetal 
 Fetal, Thymus 
The thymus gland is an organ responsible 
for immune functions lymphoepithelial 
both the uterus and out of the uterus, 
which originates embryologically from the 
third branchial pouch in the fetus, which 
appears fully developed in the 3rd. month 
of pregnancy and is composed of two 
lobes joined by a connective tissue (77). 
The thymus grows regularly during the 
period of childhood, reaching its peak in 
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the early stages of puberty and begins to 
atrophy in the early juvenile period being 
replaced by adipose tissue (69,77). 
White Blood  
 CD3+ Total Unmobilized  
 CD3+ Total Mobilized  
 CD8, Primary Cells  
 CD8, Naive Primary Cells  
 Mobilized CD8 Primary Cells
  
 CD4, Primary Cells  
 CD4, Mobilized Primary Cells
  
 CD4, Memory Primary Cells  
 CD4+ CD25- CD45RA+ Naive 
Primary Cells  
 CD4, Naive Primary Cells  
 CD4+ CD25+ CD127- Treg 
Primary Cells  
 Treg Primary Cells  
 Th17 Primary Cells  
 CD4+ CD25- IL17+ PMA-
Ionomcyin stimulated Th17 
Primary  
 CD4+ CD25- CD45RO+ Memory 
Primary Cells  
 CD4+ CD25- IL17- PMA-
Ionomycin stimulated MACS 
purified Th Primary Cells  
 CD4+ CD25- Th Primary Cells
  
 CD4+ CD25int CD127+ Tmem 
Primary Cells  
“White blood cells are also called 
leukocytes, these are an important part of 
the immune system and originate in the 
bone marrow, but circulate throughout the 
bloodstream. Its function is help fight 
infections by attacking bacteria, viruses, 
and germs that invade the body. There are 
five major types of white blood cells: 
neutrophils; lymphocytes; eosinophils; 
monocytes; basophils” (72). 
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 CD14, Primary Cells  
 CD56, Primary Cells  
 CD8, Mobilized Cells  
 CD15, Primary Cells  
 CD19, Primary Cells  
 CD20, Primary Cells  
 CD56, Mobilized Cells  
 Peripheral Blood Mononuclear 
Primary Cells  
 CD4+ CD25- CD45RA+ Naive 
Primary Cells  
 CD4+ CD25- CD45RO+ Memory 
Primary Cells 
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Annex 4 – Characteristics of each histone modification 
Histone Description 
H2A.Z “Between core histones, the H2A family exhibits highest sequence 
divergence, resulting in the largest number of variants known”. Being 
that, H2A variants differ mostly in their C-terminus. Consequently, H2A 
variant incorporation has the potential to strongly regulate DNA 
organization on several levels resulting in meaningful biological output” 
(78). 
“The H2A family, on the other hand, contains a plethora of variants with 
some ‘universal variants’ found in almost all organisms, namely H2A.Z 
and H2A.X” (78). 
Histone H2A.X was, together with H2A.Z, first described in 1980 (78). 
“After DNA damage, this serine becomes phosphorylated and renders 
H2A.X an important player in preserving genome integrity. Thus, 
H2A.X has been shown to be involved in the DNA damage response.” 
“Histone H2A.Z is an almost universal variant, which evolved early and 
suggest that H2A.Z fulfils specific and unique functions that cannot be 
carried out by other H2A variants. Like other histones, H2A.Z can be 
post-translationally modified by: H2A.Z sumoylation has been 
implicated in DNA repair in S. cerevisiae (79); ubiquitination correlates 
with localization to the inactive X chromosome in mammals (80), 
whereas N-terminal acetylation leads to nucleosome destabilization (81); 
H2A.Z acetylation works as a switch-like mechanism to modulate 
H2A.Z nucleosome stability, ascribing repressive functions to the 
unmodified and activating functions to the acetylated form. Furthermore, 
acetylated H2A.Z was found associated with transcription, revealing that 
this variant of H2 is enriched at gene promoters. It has been found that 
H2A.Z can have both activating and repressive influences on 
transcription” (78). 
“The biological function of H2A.Z has been extensively studied 
revealing roles in transcription regulation, DNA repair, heterochromatin 
formation, chromosome segregation and mitosis. Because of space 
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constraints, we cannot discuss all aspects of H2A.Z biology” (78,82). 
H2AK5ac Histone H2A Lys5 is preferentially acetylated by Tip60 and deacetylated 
by HDAC3, that causes its release from damaged chromatin and 
activates DNA damage response (83). 
H2AK9ac “All acetylations are correlated with gene expression, consistent with 
their involvement in transcriptional activation”. However, different 
acetylations may target different regions of genes. For example, 
H2AK9ac, H2BK5ac, H3K9ac, H3K18ac, H3K27ac, H3K36ac and 
H4K91ac are mainly located in the region surrounding the transcription 
start sites, whereas H2BK12ac, H2BK20ac, H2BK120ac, H3K4ac, 
H4K5ac, H4K8ac, H4K12ac and H4K16ac are elevated in the promoter 
and transcribed regions of active genes (84). 
H2BK5ac H2BK5 acetylation shows also a robust peak at the transcription start 
site of active (84). 
H2BK12ac “H2BK12 is shown to be heavily deacetylated on exposure to Nickel(II) 
which is supposed to be carcinogenic. This also show to be enriched at 
the transcription start site” (84). H2BK12 acetylation is found at 
differentially methylated regions of imprinted genes (85). 
H2BK15ac Acetylated H2BK15 levels are reported to rise after RGC-32 knockdown 
in colon cancer cell lines (86). 
H2BK20ac “H2BK20 is shown to be heavily deacetylated on exposure to Nickel(II) 
which is supposed to be carcinogenic” (87). This also show to be 
enriched at the transcription start site (84). 
H2BK120ac This another histone that show to be enriched at the transcription start 
site (84). 
H3K4ac This histone show also to be enriched at the transcription start site (84). 
H3K4me1 H3K4me1 and H3K27ac are histones that flank active enhancers. The 
enhancers that are not yet active but that are primed for activation either 
at a later developmental time point or in response to external stimuli that 
can be pre-marked by H3K4me1. “Lastly, latent enhancers are located in 
closed chromatin and are not pre-marked by known histone 
modifications, but in the presence of external stimuli the DNA becomes 
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accessible, and flanking nucleosomes acquire H3K4me1 and H3K27ac 
marks” (88). 
H3K4me2 Dimethylation of histone H3K4 is linked to active transcription (89). It 
is associated with lung cancer (90); prostate cancer (91); Kidney cancer 
(91); neurological disorders: Fragile X syndrome (92); colon cancer 
(93). 
H3K4me3 H3K4 is associated with activation.  H3K4me3 recruits the chromatin 
remodeling factors CHD1 (94) and BPTF (95) which open chromatin, 
while preventing the binding of the repressive NuRD (96) and INHAT 
complexes (97). H3K4 methylation enzymes were initially identified as 
regulators of Hox genes. So,  a relatively recent paper has further 
elucidated the mechanism by which H3K4me3 promotes rapid gene 
activation (98). 
H3K9ac H3K9 can turn genes on by getting acetylated, so how can silence them 
just as easily when methylated. H3K9ac is a particularly important 
acetylation because it is highly correlated with active promoters. 
H3K9ac also has a high co-occurrence with H3K14ac and H3K4me3 
which together are these three marks are the hallmark of active gene 
promoters (99).  
H3K9me1 There are, mono, di, and tri H3K9 methylations, being that H3K9me1 is 
enriched at the transcriptional start site of active genes (95), and 
H3K9me2/3 were both found more often at silenced genes.  
H3K9 methylation is linked to transcriptional repression. As is known 
LSD1 dependent demethylation of H3K9 leads to de-repression of 
androgen receptor target genes (100). The monomethylated H4K20 and 
H3K9 act cooperatively to mark distinct regions of silent chromatin 
within the mammalian epigenome (101). 
H3K9me3 “H3K9 methylation is the mark of heterochromatin, being that, 
heterochromatin is the condensed, transcriptionally inactive state of 
chromatin. It can be facultative or constitutive. H3K9me3 binds 
heterochromatin protein 1 (HP1) to constitutive heterochromatin (96). 
Knowing that HP1 is responsible for transcriptional repression and the 
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actual formation and maintenance of heterochromatin. HP1 also recruits 
DNA methyltransferase 3b, providing one of the best examples of the 
interplay between histone methylation and DNA methylation”. 
H3K9me3 as H3K27me3 are known for their roles associated to 
repression in the genic and nongenic regions of metazoan genomes. 
Many complexes are known to be responsible for generating these 
marks, such as polycomb group complexes and H3K9 methylases (102). 
H3K14ac “Histone H3K14 acetylation is critical for the recruitment of TFIID at 
the IFN-gamma locus, so it is  important for eliciting proper immune 
response” (103). 
H3K18ac Studies show a significant correlation between low expression of 
H3K18ac and better prognosis of patients with esophageal squamous 
cell carcinoma (104). H3K18 acetylation shows a robust peak at the 
transcription start site of active and poised genes (84). It is associated 
with prostate cancer (105); lung cancer (91); kidney cancer (91); brain 
tumor (glioblastoma) (105). 
H3K23ac H3K23 acetylation and H3K4 methylation are part of a non-canonical 
histone signature that is recognised by chromatin regulator tripartite 
motif-containing 24 (TRIM24) which binds chromatin and oestrogen 
receptor to activate the oestrogen-dependent genes associated with 
cellular proliferation and tumour development. The aberrant expression 
of TRIM24 negatively correlates with survival of breast cancer patients 
(106). 
H3K23me2 H3K23 is extensively modified by methylation and that H3K9me3 is 
exclusively detected on histone tails with H3K23me2. 
 The histone H3K23me2 is enriched in heterochromatic regions. The 
chromatin immunoprecipitation approaches revealed a positive 
correlation between H3K23me2 and repressive marks, and by 
immunofluorescence analyses, H3K23me2 appears differentially 
regulated in germ and somatic cells, in part by the action of the histone 
demethylase JMJD-1.2. Thus, This defines repressive domains and 
contributes to organizing the genome in distinct heterochromatic regions 
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during embryogenesis (107). 
H3K27ac Since a lysine residue cannot be both methylated and acetylated you 
would expect H3K27ac to be antagonistic to the repression of gene 
expression by H3K27me2/3. Indeed, data are showing that H3K27ac is 
associated with active transcription and antagonism of H3K27me3 
regulated genes (108). 
H3K27me3 H3K27 is known for shutting down transcription. H3K27 is associated 
with inactive gene promoters when it is trimethylated. This histone acts 
in opposition to H3K4me3. As is already known, the most histone 
methylations are catalysed by many enzymes but H3K27me3 has only 
one known methyltransferase: EZH2 (109). “EZH2 is part of the PRC2 
complex which is responsible for the repression many genes involved in 
development and cell differentiation” (110,111). So, it is believed that 
H3K27me3 is critical for the repression of developmental genes and she 
is also an important mark of the inactive X chromosome (112) . 
H3K36me3 H3K36 plays a role in transcriptional activation (113). “The histone may 
have a change mono, di, and trimethylation, and this states differ from 
each other in their distributions and functional roles. About the role of 
H3K36me1 remains unclear; however, H3K36me2 is relatively well 
characterized; for example, H3K36me2 has a role in double-strand break 
repair. H3K36me2 is deposited near the double-strand breaks early, and 
then serves to recruit early repair factors such as NBS1 and Ku70” 
(114). 
H3K36me3 is involved in defining exons. Exons are enriched in 
nucleosomes in general, but these nucleosomes are also enriched in 
certain histone modifications including H3K79, H4K20, and especially 
H3K36me3. It is believed that this pattern influences alternative splicing 
in some way, perhaps by signalling effector proteins to mark particular 
exons for inclusion in the final transcript (115). 
H3K56ac Histone H3 acetylated at Lysine 56 is assembled into chromatin in 
human cells, forming foci that colocalise with sites of DNA repair. 
Acetylation this histone is increased in multiple types of cancer, 
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correlating with increased levels of the histone chaperone ASF1A, in 
these tumours. “ASF1A is required for the acetylation and CAF-1 is 
required for the incorporation of acetylated H3 into the nucleosome” 
(116). “H3K56ac levels in human cells are differentially regulated at 
telomeres and globally in response to cell cycle arrest” (117). During 
DNA damage, H3K56 acetylation levels increased, as this acetylated 
H3K56 is also localised at the DNA repair sites. It also colocalised with 
other proteins involved in DNA damage signalling pathways including 
phospho-ATM, Chk2, and p53 argue its involvement in DNA damage 
repair (118). 
H3K79me1 “The methylation of histone H3 K 79 was the first modification 
identified in the globular core domain of the histones”. 
Studies suggest that specific H3K79 methylation states play distinct 
roles in the response to UV-induced DNA damage, so H3K79me is 
associated with DNA double-strand break (DSB) responses (119). 
H3K79me2 “H3K79 dimethylation is cell cycle dependent”. This histone level 
decreases during S phase, reaches its lowest level in G2, increases 
during M phase, and keeps at a high level during G1 phase (120,121). 
H3T11ph H3T11 phosphorylation is a mitosis specific modification (122). It is 
phosphorylated at androgen receptor gene targets by PRN1 which acts as 
a co-activator of androgen receptor dependent transcription. Besides that 
promotes demethylation of histone H3 'Lys-9' (H3K9me) by JMJD2C. 
The levels of PRK1 and phosphorylated H3T11 correlate with Gleason 
scores of prostate carcinomas (123). 
H4K5ac “H4K5 is the closest lysine residue to the N-terminal tail of histone H4 
and the histone H4 forms a strong tetramer with histone H3. As histone 
H3, H4 has a long N-terminal tail that is subject to various acetylations 
and methylations that are associated with many cellular processes” 
(124). 
“H4K5 is acetylation, and it is implicated in epigenetic bookmarking, in 
other words, Epigenetic bookmarking the name given to a proposed 
process that allows gene expression patterns to be faithfully passed to 
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daughter cells through mitosis. Important cell-type specific genes are 
marked in some way that prevents them from being compacted during 
mitosis and ensures their rapid transcription. H4K5ac has been 
implicated as one such mark” (125).  
“Zhao et al. (2011) found that transcriptional activity during interphase 
causes acetylation of H4K5 and H4K12 which are passed through 
mitosis. These marks then recruit BRD4 which de-compacts the local 
chromatin environment and permits transcriptional activation. Similarly, 
other papers have found that H4K5ac can serve as a primer for rapid 
transcription in other contexts, such as, H4K5ac appears to prime 
activity-dependent genes expressed during learning (126). The mark 
may permit the rapid expression of certain genes required during the 
learning process”. 
H4K8ac H4K8 is another lysine on that tail of histone H4 and it is only known to 
be acetylated. This group of lysines are known to act as transcriptional 
activators (84). This proposes that H4K8ac serves to facilitate 
transcriptional elongation (127). 
Wang et al. (2008), found that H4K8ac is part of 17 modifications that 
occupy most active promoters. This study also found that H4K8ac was 
found more often in active promoters and transcribed regions than the 
others groups which were found more at transcriptional start sites. 
H4K8ac is catalyzed and read by a slightly different group of enzymes 
than other H4 lysines, mMany acetyltransferases catalyze H4K8ac 
(128). 
H4K12ac Like H4K8ac, H4K12ac is part of a “backbone” of histone modifications 
that are associated with active promoters (84). H4K12ac is localized to 
the promoter, like other H4 acetylations (84).  
H4K12ac appears to be vital for learning and memory. One study 
showed its importance in controlling gene expression in the 
hippocampus associated with memory consolidation, and showed also 
that normal age-related decline in memory could be ameliorated by 
restoration of H4K12ac (127).  
“Recently it has been shown that H4K12ac is important in paternal 
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influence on early gene expression in the zygote. Sperm chromatin is 
packaged with protamines instead of histones for the majority (85%) of 
the genome, serving to inactivate transcription. The rest of the genome is 
occupied by the traditional histone octamers. Data have shown some of 
this remaining portion of the chromatin bear H4 lysine acetylations that 
are passed into the zygote and can be involved in early embryo 
development” (129).  
Other studies found that H4K12ac was enriched surrounding 
transcriptional start sites, and that the genes it occupied had a significant 
bias toward developmental functions (130).  
H4K20me1 H4K20 is methylated but not acetylated. Like all lysine residues, H4K20 
can be mono, di, or tri methylated, and these methylation states have 
different spatial disruptions and functions.  
H4K20me1 is associated with transcriptional activation, being that the 
most highly transcribed group of genes tend to have H4K20me1 present 
in addition to the core group of modifications at active promoters (79). 
“H4K20me1 is also important for cell cycle regulation, because PR-Set7 
(enzyme that catalyses this modification) levels oscillate during the cell 
cycle, and regulate chromatin condensation and mitotic progression” 
(84,131). 
H4K20me2 is important for cell cycle control, particularly for marking 
points of origin for DNA replication, and it is also important in the DNA 
damage response (132,133). 
“H4K20me3 have a much different function that the other two 
methylation states. Usually, H4K20me3 is associated with repression of 
transcription when present at promoters and it is also important for the 
silencing of repetitive DNA and transposons (134). These results can 
explain why the loss of H4K20me3 has be identified as a hallmark of 
cancer. Along with reduction of H4K16ac, loss of H4K20me3 is a near 
universal characteristic of human cancers” (135).  
H4K91ac “Histone H4 showed the presence of modifications in the globular core 
domain. One site of acetylation, lysine 91, localizes to a region of H4 
that is important for the interaction of the H3/H4 tetramer with 
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H2A/H2B dimers” (136).  
So, the molecular genetics and biochemical evidence indicate that the 
acetylation of lysine 91 influences the process of chromatin assembly 
and may function to modulate the formation of histone octamers. Having 
thus, increased sensitivity to DNA damaging agents (136). 
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Annex 5 – R scripts 
R scripts used in program R throughout this work: 
For deliver these outcomes, it was necessary to read a frag-stats file and complete it 
with oligonucleotide frequency counts of a context around each variation. I am grateful 
to teacher João Rodrigues of DETI, for providing this function, although we have 
adapted to our work. 
R scripts used: 
 
 
As our files taken from the database, had multiple columns with different 
information, we had to create a function to just stay with the columns that interest to get 
the results, meaning, take the last two columns (metadata), being one optional variable. 
R scripts used: 
 
 
To reading of the bed file may be compressed or not. Where can we read only the 
first 100 line, for exemple ("Nrow = 100"). And we also have to give an indication to 
read only the columns that interests us ("ColClasses = colClasses"). 
Our file changed its name to "t". 
R scripts used: 
 
 
The next function is to know how many chromosomes have our file "t". 
R scripts used: 
 
 
In order to see the top of the table that will work just this function. 
R scripts used: 
 
 
It will be not our case, but if we want to filter out only a chromosome analysis is 
also possible, for example, chromosome 1. 
R scripts used: 
unique(t) 
 
head(t) 
source("read-frag-stats-pos2.R") 
colClasses=c(NA, NA, NA,"NULL","NULL") 
 
t = read.table("File.bed.gz", colClasses=colClasses, nrow=100) 
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To obtaining the size of the object. 
R scripts used: 
 
 
The command used for the frequencies of oligonucleotides, has a set of functions. 
But before applying this command, we had to create a function to exclude the 
mitochondria because they do not want to include in our analysis. 
R scripts used: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To get these results in excel, we have to install a package ("Write.xlsx") and create 
a role, giving the file a name. 
R scripts used: 
 
 
 
This program can also read files from Excel. 
R scripts used: 
 
t=t[t$CHROM=="chr1",] 
 
dim(t) 
 
# Exclude the mitochondria 
level=levels(t$CHROM) 
level=level[level!="chrM"]        
# For nucleotides, for example 
k=1 
Tc = c(1:4^k) 
for (chr in level){ 
t1=t[t$CHROM==chr,] 
tt = oligonucleotideFrequency.frag.neighborhood.pos2(t1, k)      
Tc=cbind(Tc,colSums(tt)) 
} 
 
colnames(Tc) <- c("Tc", level) 
 
 
Dat  data.frame(what we save) 
write.table(dat, "name.txt") 
 
read.xlsx("name.xlsx", 1) 
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After having the first part of the intended results, we want to do statistical analysis. 
To do this, we use the previous command for read files from Excel, and we name the 
columns. Thus started doing the statistical analysis: 
R scripts used: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
#Read files from Excel 
library("xlsx") 
a = read.xlsx("name.xlsx", 1) 
# Identify the columns in the program for nucleotides, for example 
rownames(a) <-  c("A", "C", "G", "T") 
# Or identify the columns in the program for dinucleotide 
rownames(a) <-  c("AA", "AC", "AG", "AT", "CA", "CC", "CG", "CT", "GA", 
"GC", "GG", "GT", "TA", "TC", "TG", "TT")   
# Calculate the chi-square test 
x = chisq.test(a)       
# Calculate the analysis of standardized residuals 
p= x$stdres           
# Get the two-dimensional representation of data in which values are represented 
by colors 
library(gplots) 
my_palette=colorRampPalette(c("red", "orange", "black", "yellow", "green"))(n = 
999) 
colors=c(seq(-1000,-101,length=200),seq(-100,-11,length=200),seq(-
10,10,length=200),seq(11,100,length=200), seq(101,1000,length=200)) 
heatmap.2(p, col=my_palette, breaks=colors) 
# Calculate the measure of association Cramer’s V. 
library(questionr) 
v=cramer.v(a)           
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For the completion of the control we had to complementary. For this we use the 
package GenomicRanges. 
R scripts used: 
 
 
 
 
 
 
source("http://bioconductor.org/biocLite.R") 
biocLite("Biostrings") 
library(IRanges) 
library(GenomicRanges) 
 
colClasses=c(NA, NA, NA,"NULL","NULL")          
t = read.table("union.bed.gz", colClasses=colClasses) 
names(t)=c("CHROM","POS1","POS2")                  Put names in columns 
B=IRanges(start=t[[2]], end=t[[3]]) 
grB <- GRanges(t[[1]], B, strand="+") 
grB 
 
require(xlsx)  
C0=read.xlsx("control0.xlsx", 1) 
A=IRanges(start=C0[[2]], end=C0[[3]]) 
grA <- GRanges(C0[[1]], A, strand="+") 
D=setdiff(grB, grA) 
grB=setdiff(grB,D) 
 
D=setdiff(grA, grB) 
aux=seqnames(D) 
aux<- data.frame(aux) 
Pos=ranges(D) 
Pos<- data.frame(Pos) 
control=cbind(aux,Pos) 
names(control)=c("CHROM","POS1","POS2") 
 
# Exclude the mitochondria 
level=levels(control$CHROM) 
level=level[level!="chrM"]  
 
# This function is necessary to read a snp-stats file and complete it with 
oligonucleotide frequency counts of a context around each variation             
source("read-snp-stats-pos2.R") 
 
# The command used for the frequencies of oligonucleotides 
k=1 (nucleotide, for exemple) 
Tc = c(1:4^k) 
for (chr in level){ 
t1=control[control$CHROM==chr,] 
tt = oligonucleotideFrequency.frag.neighborhood.pos2(t1, k) 
Tc=cbind(Tc,colSums(tt)) 
} 
colnames(Tc) <- c("Tc", level) 
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Annex 6 – Histone union and histone intersection 
 
  Union Intersection 
  X2 df p-
value 
Cramer's 
V 
X2 df p-
value 
Cramer's V 
H2AZ Nucleotide 10063000 69 <0.001 0.0243386 79652 69 <0.001 0.01740994 
 Dinucleotide 22290000 345 <0.001 0.0161998 214010 345 <0.001 0.01283165 
 Trinucleotide 34156000 1449 <0.001 0.01619488 376980 1449 <0.001 0.01382865 
 Tetranucleotide 46218000 5865 <0.001 0.01883907 678130 5865 <0.001 0.01864872 
          
H2AK5ac Nucleotide 8398000 69 <0.001 0.02319443 9629.3 69 <0.001 0.0128653 
 Dinucleotide 18742000 345 <0.001 0.01550353 28476 345 <0.001 0.01018692 
 Trinucleotide 28852000 1449 <0.001 0.01554196 51427 1449 <0.001 0.01140307 
 Tetranucleotide 39203000 5865 <0.001 0.01812571 98694 5865 <0.001 0.01629836 
          
H2AK9ac Nucleotide 1182900 69 <0.001 0.01774537 173590 69 <0.001 0.01755841 
 Dinucleotide 2773900 345 <0.001 0.01227663 422120 345 <0.001 0.01249854 
 Trinucleotide 4317600 1449 <0.001 0.01249791 673980 1449 <0.001 0.01302934 
 Tetranucleotide 5965200 5865 <0.001 0.01484653 1021600 5865 <0.001 0.01639573 
          
H2BK5ac Nucleotide 8423500 69 <0.001 0.02330746 3255.7 69 <0.001 0.02197853 
 Dinucleotide 18777000 345 <0.001 0.01557157 11069 345 <0.001 0.01870049 
 Trinucleotide 28863000 1449 <0.001 0.01560005 23946 1449 <0.001 0.02296858 
 Tetranucleotide 39156000 5865 <0.001 0.01818094 59139 5865 <0.001 0.03732939 
          
H2BK12ac Nucleotide 7360200 69 <0.001 0.02241408 8573.9 69 <0.001 0.01376977 
 Dinucleotide 16525000 345 <0.001 0.01502819 27334 345 <0.001 0.01128178 
 Trinucleotide 25521000 1449 <0.001 0.01509051 53095 1449 <0.001 0.01304699 
 Tetranucleotide 34780000 5865 <0.001 0.01762608 112950 5865 <0.001 0.0195584 
          
H2BK15ac Nucleotide 8627700 69 <0.001 0.02335652 29197 69 <0.001 0.01503076 
 Dinucleotide 19239000 345 <0.001 0.01560198 83473 345 <0.001 0.01146271 
 Trinucleotide 29612000 1449 <0.001 0.01563603 152830 1449 <0.001 0.0126342 
 Tetranucleotide 40231000 5865 <0.001 0.01823015 290440 5865 <0.001 0.01756811 
          
H2BK20ac Nucleotide 7304500 69 <0.001 0.02279845 220730 69 <0.001 0.01713053 
 Dinucleotide 16375000 345 <0.001 0.01527556 560850 345 <0.001 0.01227545 
 Trinucleotide 25219000 1449 <0.001 0.01531888 965860 1449 <0.001 0.01307765 
 Tetranucleotide 34255000 5865 <0.001 0.01786481 1607900 5865 <0.001 0.01696204 
          
H2BK120ac Nucleotide 7805600 69 <0.001 0.02273214 8541.2 69 <0.001 0.02069741 
 Dinucleotide 17470000 345 <0.001 0.01521481 36763 345 <0.001 0.01937769 
 Trinucleotide 26933000 1449 <0.001 0.01526231 103870 1449 <0.001 0.02654775 
 Tetranucleotide 36649000 5865 <0.001 0.01781086 263890 5865 <0.001 0.0427055 
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H3K4ac Nucleotide 7785600 69 <0.001 0.02261121 7265.7 69 <0.001 0.01574844 
 Dinucleotide 17437000 345 <0.001 0.01513886 22648 345 <0.001 0.01277403 
 Trinucleotide 26915000 1449 <0.001 0.01519519 43784 1449 <0.001 0.01475758 
 Tetranucleotide 36661000 5865 <0.001 0.01774081 98015 5865 <0.001 0.02272458 
          
H3K4me1 Nucleotide 10061000 69 <0.001 0.02438253 358.9 63 <0.001 0.07653186 
 Dinucleotide 22283000 345 <0.001 0.01622801 1339 315 <0.001 0.06700341 
 Trinucleotide 34137000 1449 <0.001 0.01622122 3669.1 1323 <0.001 0.0950398 
 Tetranucleotide 46181000 5865 <0.001 0.01886729 10443 5355 <0.001 0.1625373 
          
H3K4me2 Nucleotide 9039200 69 <0.001 0.02374319 15963 69 <0.001 0.01212389 
 Dinucleotide 20109000 345 <0.001 0.01584191 49321 345 <0.001 0.009621216 
 Trinucleotide 30882000 1449 <0.001 0.01585863 83609 1449 <0.001 0.01021452 
 Tetranucleotide 41854000 5865 <0.001 0.0184672 139300 5865 <0.001 0.01331299 
          
H3K4me3 Nucleotide 10053000 69 <0.001 0.02437461 606.25 69 <0.001 0.007432931 
 Dinucleotide 22266000 345 <0.001 0.01622313 2717.3 345 <0.001 0.007072333 
 Trinucleotide 34112000 1449 <0.001 0.0162168 6783.5 1449 <0.001 0.009069115 
 Tetranucleotide 46149000 5865 <0.001 0.01886267 18124 5865 <0.001 0.01489811 
          
H3K9ac Nucleotide 10051000 69 <0.001 0.02443599 3289.1 69 <0.001 0.0188334 
 Dinucleotide 22258000 345 <0.001 0.01626303 10720 345 <0.001 0.01550041 
 Trinucleotide 34087000 1449 <0.001 0.01625357 22552 1449 <0.001 0.01852131 
 Tetranucleotide 46097000 5865 <0.001 0.01890194 54964 5865 <0.001 0.02949854 
          
H3K9me1 Nucleotide 3881400 69 <0.001 0.02149542 860540 69 <0.001 0.01698349 
 Dinucleotide 8815500 345 <0.001 0.01450667 2044500 345 <0.001 0.01173788 
 Trinucleotide 13628000 1449 <0.001 0.0145853 3225500 1449 <0.001 0.01193756 
 Tetranucleotide 18645000 5865 <0.001 0.01708301 4520100 5865 <0.001 0.01416892 
          
H3K9me3 Nucleotide 10042000 69 <0.001 0.0243372 22073 69 <0.001 0.1135579 
 Dinucleotide 22244000 345 <0.001 0.01619933 65987 345 <0.001 0.08876235 
 Trinucleotide 34086000 1449 <0.001 0.01619454 100910 1071 <0.001 0.1193135 
 Tetranucleotide 46124000 5865 <0.001 0.01883876 259800 5865 <0.001 0.1454109 
          
H3K14ac Nucleotide 7585300 69 <0.001 0.02253996 16731 69 <0.001 0.01197144 
 Dinucleotide 17012000 345 <0.001 0.01510283 57183 345 <0.001 0.01010639 
 Trinucleotide 26264000 1449 <0.001 0.01516113 103060 1449 <0.001 0.01119785 
 Tetranucleotide 35772000 5865 <0.001 0.01770167 182400 5865 <0.001 0.01522907 
          
H3K18ac Nucleotide 7550800 69 <0.001 0.02269826 4563.3 69 <0.001 0.01032337 
 Dinucleotide 16916000 345 <0.001 0.01520117 15231 345 <0.001 0.00860872 
 Trinucleotide 26060000 1449 <0.001 0.0152445 27071 1449 <0.001 0.009468009 
 Tetranucleotide 35450000 5865 <0.001 0.0177888 45256 5865 <0.001 0.01250661 
          
H3K23ac Nucleotide 7884200 69 <0.001 0.02273375 7018.9 69 <0.001 0.03026076 
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 Dinucleotide 17646000 345 <0.001 0.01521959 29733 345 <0.001 0.02902337 
 Trinucleotide 27218000 1449 <0.001 0.01527417 83980 1449 <0.001 0.04119723 
 Tetranucleotide 37041000 5865 <0.001 0.01782954 190730 5865 <0.001 0.06494022 
          
H3K23me2 Nucleotide 6442300 69 <0.001 0.02278135 79449 69 <0.001 0.01745818 
 Dinucleotide 14493000 345 <0.001 0.0152989 204700 345 <0.001 0.01271728 
 Trinucleotide 22282000 1449 <0.001 0.01533763 374370 1449 <0.001 0.0141002 
 Tetranucleotide 46218000 5865 <0.001 0.01883907 720550 5865 <0.001 0.019865 
          
H3K27ac Nucleotide 10058000 69 <0.001 0.02440445 1327.7 54 <0.001 0.01985795 
 Dinucleotide 22276000 345 <0.001 0.01624317 3342.8 270 <0.001 0.01419714 
 Trinucleotide 34125000 1449 <0.001 0.01623601 7290.1 1134 <0.001 0.01928499 
 Tetranucleotide 46160000 5865 <0.001 0.0188838 18297 4590 <0.001 0.03078512 
          
H3K27me3 Nucleotide 10052000 69 <0.001 0.02435711 1750.1 69 <0.001 0.06224492 
 Dinucleotide 22264000 345 <0.001 0.01621153 8013.2 345 <0.001 0.06022942 
 Trinucleotide 34112000 1449 <0.001 0.01620582 22493 1449 <0.001 0.08241953 
 Tetranucleotide 46153000 5865 <0.001 0.01885075 50705 5865 <0.001 0.1251495 
          
H3K36me3 Nucleotide 10054000 69 <0.001 0.02436328 1249 69 <0.001 0.05107377 
 Dinucleotide 22267000 345 <0.001 0.01621573 7368.2 345 <0.001 0.05637531 
 Trinucleotide 34117000 1449 <0.001 0.01620988 22085 1449 <0.001 0.08013865 
 Tetranucleotide 46159000 5865 <0.001 0.01885508 50380 5865 <0.001 0.1230405 
          
H3K56ac Nucleotide 7297300 69 <0.001 0.02276179 62668 69 <0.001 0.01947377 
 Dinucleotide 16346000 345 <0.001 0.01524534 204440 345 <0.001 0.01583134 
 Trinucleotide 25151000 1449 <0.001 0.01528214 489610 1449 <0.001 0.01991447 
 Tetranucleotide 34126000 5865 <0.001 0.0178132 1127500 5865 <0.001 0.03041842 
          
H3K79me1 Nucleotide 8099300 69 <0.001 0.02289817 10838 69 <0.001 0.020081 
 Dinucleotide 18077000 345 <0.001 0.01530745 42645 345 <0.001 0.0183584 
 Trinucleotide 27837000 1449 <0.001 0.01534884 122370 1449 <0.001 0.02593187 
 Tetranucleotide 37831000 5865 <0.001 0.01790355 312210 5865 <0.001 0.04278113 
          
H3K79me2 Nucleotide 7937500 69 <0.001 0.02282001 50729 69 <0.001 0.01395807 
 Dinucleotide 17756000 345 <0.001 0.01527137 135350 345 <0.001 0.01028522 
 Trinucleotide 27373000 1449 <0.001 0.01532011 248100 1449 <0.001 0.01134579 
 Tetranucleotide 37227000 5865 <0.001 0.01787507 472360 5865 <0.001 0.01579449 
          
H3T11ph Nucleotide 1236100 69 <0.001 0.02116811 1236100 69 <0.001 0.02116811 
 Dinucleotide 2770600 345 <0.001 0.01434907 2770600 345 <0.001 0.01434907 
 Trinucleotide 4221300 1449 <0.001 0.0144861 4221300 1449 <0.001 0.0144861 
 Tetranucleotide 5723700 5865 <0.001 0.01708886 5723700 5865 <0.001 0.01708886 
          
H4K5ac Nucleotide 7839600 69 <0.001 0.02346504 7839600 69 <0.001 0.02346504 
 Dinucleotide 17513000 345 <0.001 0.01569392 17513000 345 <0.001 0.01569392 
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 Trinucleotide 26869000 1449 <0.001 0.01570743 26869000 1449 <0.001 0.01570743 
 Tetranucleotide 36369000 5865 <0.001 0.0182854 880560 5865 <0.001 0.01597168 
          
H4K8ac Nucleotide 6773900 69 <0.001 0.0220494 2167.1 69 <0.001 0.01534723 
 Dinucleotide 15240000 345 <0.001 0.01479986 8737.9 345 <0.001 0.01409647 
 Trinucleotide 23529000 1449 <0.001 0.01486008 19375 1449 <0.001 0.01735714 
 Tetranucleotide 32062000 5865 <0.001 0.01735739 48831 5865 <0.001 0.02822063 
          
H4K12ac Nucleotide 2366200 69 <0.001 0.01764977 500900 69 <0.001 0.01352 
 Dinucleotide 5546300 345 <0.001 0.01210017 1273800 345 <0.001 0.009666201 
 Trinucleotide 8719000 1449 <0.001 0.01226792 2082100 1449 <0.001 0.01000513 
 Tetranucleotide 12066000 5865 <0.001 0.01445066 3010800 5865 <0.001 0.01206156 
          
H4K20me1 Nucleotide 6190100 69 <0.001 0.02216194 42804 69 <0.001 0.0155282 
 Dinucleotide 13970000 345 <0.001 0.01490241 125030 345 <0.001 0.01193584 
 Trinucleotide 21603000 1449 <0.001 0.01497875 257350 1449 <0.001 0.01390832 
 Tetranucleotide 29456000 5865 <0.001 0.01750593 546420 5865 <0.001 0.02038286 
          
H4K91ac Nucleotide 6653000 69 <0.001 0.02194719 10784 69 <0.001 0.01419887 
 Dinucleotide 14995000 345 <0.001 0.01474491 36701 345 <0.001 0.01196824 
 Trinucleotide 23185000 1449 <0.001 0.01481648 74993 1449 <0.001 0.01412876 
 Tetranucleotide 31613000 5865 <0.001 0.01731289 165280 5865 <0.001 0.02145625 
 
 
Chi-square test value for histone union and histone intersection. X
2
 matches chi-square 
test; df matches degrees of freedom; p-value matches p value; Cramer's V matches 
measure of association Cramer's V. 
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Annex 7 – Comparing to the each histone with control 
 
  Union 
  X
2 
df p-value Cramer's V 
H2AZ Nucleotide 8969.3 3 <0.001 0.001256411 
 Dinucleotide 29912 15 <0.001 0.002294481 
 Trinucleotide 54176 63 <0.001 0.003087987 
 Tetranucleotide 91899 255 <0.001 0.004021933 
      
H2AK5ac Nucleotide 464.68 3 <0.001 0.0002982823 
 Dinucleotide 11310 15 <0.001 0.001472304 
 Trinucleotide 26998 63 <0.001 0.002275844 
 Tetranucleotide 58741 255 <0.001 0.003358645 
      
H2AK9ac Nucleotide 252440 3 <0.001 0.01409013 
 Dinucleotide 596720 15 <0.001 0.0218812 
 Trinucleotide 904450 63 <0.001 0.02721546 
 Tetranucleotide 1211300 255 <0.001 0.03182611 
      
H2BK5ac Nucleotide 663.61 3 <0.001 0.0003576462 
 Dinucleotide 11897 15 <0.001 0.001515236 
 Trinucleotide 28053 63 <0.001 0.002328113 
 Tetranucleotide 60067 255 <0.001 0.003408693 
      
H2BK12ac Nucleotide 1044.7 3 <0.001 0.0004615974 
 Dinucleotide 12950 15 <0.001 0.001626103 
 Trinucleotide 29959 63 <0.001 0.002474678 
 Tetranucleotide 64201 255 <0.001 0.003624668 
      
H2BK15ac Nucleotide 1287 3 <0.001 0.0004931837 
 Dinucleotide 13187 15 <0.001 0.001579155 
 Trinucleotide 29794 63 <0.001 0.002374258 
 Tetranucleotide 62123 255 <0.001 0.003429333 
      
H2BK20ac Nucleotide 461.94 3 <0.001 0.0003133779 
 Dinucleotide 12502 15 <0.001 0.001631332 
 Trinucleotide 29478 63 <0.001 0.00250655 
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 Tetranucleotide 62291 255 <0.001 0.003646035 
      
H2BK120ac Nucleotide 32.93 3 <0.001 8.071568e-05 
 Dinucleotide 10381 15 <0.001 0.001433721 
 Trinucleotide 26085 63 <0.001 0.002273574 
 Tetranucleotide 58877 255 <0.001 0.003417123 
      
H3K4ac Nucleotide 5.044 3 <0.001 3.146293e-05 
 Dinucleotide 10499 15 <0.001 0.001435971 
 Trinucleotide 26114 63 <0.001 0.002265604 
 Tetranucleotide 58374 255 <0.001 0.003388623 
      
H3K4me1 Nucleotide 8874.5 3 <0.001 0.001252109 
 Dinucleotide 29748 15 <0.001 0.002292513 
 Trinucleotide 54002 63 <0.001 0.003088855 
 Tetranucleotide 91853 255 <0.001 0.004028558 
      
H3K4me2 Nucleotide 3536.2 3 <0.001 0.0008119262 
 Dinucleotide 18444 15 <0.001 0.001854808 
 Trinucleotide 37575 63 <0.001 0.002648153 
 Tetranucleotide 71300 255 <0.001 0.0036489 
      
H3K4me3 Nucleotide 8933 3 <0.001 0.001256336 
 Dinucleotide 29887 15 <0.001 0.002298042 
 Trinucleotide 54205 63 <0.001 0.00309493 
 Tetranucleotide 92103 255 <0.001 0.004034413 
      
H3K9ac Nucleotide 8945.7 3 <0.001 0.001260505 
 Dinucleotide 30059 15 <0.001 0.002310687 
 Trinucleotide 54655 63 <0.001 0.003115917 
 Tetranucleotide 93103 255 <0.001 0.004066966 
      
H3K9me1 Nucleotide 22465 3 <0.001 0.002822762 
 Dinucleotide 66619 15 <0.001 0.004867332 
 Trinucleotide 114030 63 <0.001 0.00637644 
 Tetranucleotide 179300 255 <0.001 0.008006405 
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H3K9me3 Nucleotide 8944.6 3 <0.001 0.001255921 
 Dinucleotide 29882 15 <0.001 0.002295626 
 Trinucleotide 54144 63 <0.001 0.003090135 
 Tetranucleotide 91891 255 <0.001 0.004025783 
      
H3K14ac Nucleotide 273.29 3 <0.001 0.0002338814 
 Dinucleotide 11340 15 <0.001 0.001507276 
 Trinucleotide 27424 63 <0.001 0.002344976 
 Tetranucleotide 60240 255 <0.001 0.003477008 
      
H3K18ac Nucleotide 1213.1 3 <0.001 0.0004973358 
 Dinucleotide 12927 15 <0.001 0.001624284 
 Trinucleotide 30440 63 <0.001 0.002493756 
 Tetranucleotide 66355 255 <0.001 0.003683706 
      
H3K23ac Nucleotide 23.462 3 <0.001 6.779707e-05 
 Dinucleotide 10526 15 <0.001 0.001436914 
 Trinucleotide 26032 63 <0.001 0.002261107 
 Tetranucleotide 57795 255 <0.001 0.003371208 
      
H3K23me2 Nucleotide 4732.6 3 <0.001 0.001066978 
 Dinucleotide 21307 15 <0.001 0.002266581 
 Trinucleotide 41982 63 <0.001 0.003185364 
 Tetranucleotide 91899 255 <0.001 0.004021933 
      
H3K27ac Nucleotide 8831.8 3 <0.001 0.00125044 
 Dinucleotide 29686 15 <0.001 0.002292614 
 Trinucleotide 53938 63 <0.001 0.003090396 
 Tetranucleotide 91845 255 <0.001 0.004032803 
      
H3K27me3 Nucleotide 8922.9 3 <0.001 0.001254797 
 Dinucleotide 29849 15 <0.001 0.002295087 
 Trinucleotide 54124 63 <0.001 0.003090567 
 Tetranucleotide 91931 255 <0.001 0.004027942 
      
H3K36me3 Nucleotide 8905.2 3 <0.001 0.001253761 
 Dinucleotide 29800 15 <0.001 0.002293578 
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 Trinucleotide 54049 63 <0.001 0.003088949 
 Tetranucleotide 91851 255 <0.001 0.004026886 
      
H3K56ac Nucleotide 285.29 3 <0.001 0.0002460015 
 Dinucleotide 11985 15 <0.001 0.001595525 
 Trinucleotide 28666 63 <0.001 0.00246921 
 Tetranucleotide 60614 255 <0.001 0.003592993 
      
H3K79me1 Nucleotide 465.71 3 <0.001 0.0003001791 
 Dinucleotide 11360 15 <0.001 0.001483417 
 Trinucleotide 27329 63 <0.001 0.002302114 
 Tetranucleotide 59456 255 <0.001 0.003397546 
      
H3K79me2 Nucleotide 93.798 3 <0.001 0.0001356138 
 Dinucleotide 10702 15 <0.001 0.001449282 
 Trinucleotide 26253 63 <0.001 0.002271053 
 Tetranucleotide 57912 255 <0.001 0.003374742 
      
H3T11ph Nucleotide 22900 3 <0.001 0.004938626 
 Dinucleotide 63722 15 <0.001 0.00833877 
 Trinucleotide 106090 63 <0.001 0.01089437 
 Tetranucleotide 161690 255 <0.001 0.01362157 
      
H4K5ac Nucleotide 281.9 3 <0.001 0.0002432175 
 Dinucleotide 11665 15 <0.001 0.001565502 
 Trinucleotide 28709 63 <0.001 0.002457397 
 Tetranucleotide 62241 255 <0.001 0.00362042 
      
H4K8ac Nucleotide 4612.3 3 <0.001 0.000994479 
 Dinucleotide 20489 15 <0.001 0.002097331 
 Trinucleotide 41790 63 <0.001 0.002997183 
 Tetranucleotide 81665 255 <0.001 0.004192455 
      
H4K12ac Nucleotide 219740 3 <0.001 0.009280546 
 Dinucleotide 522470 15 <0.001 0.01432888 
 Trinucleotide 794490 63 <0.001 0.01769254 
 Tetranucleotide 1076700 255 <0.001 0.02062374 
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H4K20me1 Nucleotide 6182.6 3 <0.001 0.001210335 
 Dinucleotide 25005 15 <0.001 0.002436217 
 Trinucleotide 48282 63 <0.001 0.003388234 
 Tetranucleotide 87970 255 <0.001 0.004577497 
      
H4K91ac Nucleotide 4812.4 3 <0.001 0.001020235 
 Dinucleotide 21666 15 <0.001 0.00216619 
 Trinucleotide 43102 63 <0.001 0.003057366 
 Tetranucleotide 81702 255 <0.001 0.004212164 
 
Chi-square test value for comparing to the each histone with the control. X
2
 matches 
chi-square test; df matches degrees of freedom; p-value matches p value; Cramer's V 
matches measure of association Cramer's V. 
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Annex 8 – Heatmaps 
 
Heatmaps corresponding to the analysis the comparing the total of genomes with to 
control, to understand if the context of epigenetic marking the chromosomes is equal to 
the epigenetic marking context in control. 
 Analysis union-control for nucleotide: 
 
 
 
 
 Analysis union-control for trinucleotide: 
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 Analysis union-control for tetranucleotide: 
 
 
 Analysis inter-control for trinucleotide: 
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 Analysis inter-control for tetranucleotide: 
 
 
 
 
Heatmaps that we see if the context of epigenetic marking is homogeneous among 
histones, for histone union and histone intersection. 
 Histone union for dinucleotide: 
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 Histone union for trinucleotide: 
 
 
 
 Histone union for tetranucleotide: 
 
 
 Histone intersection for dinucleotide: 
116 
 
 
 
 Histone intersection for trinucleotide: 
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 Histone intersection for tetranucleotide: 
 
 
 
 
Heatmaps corresponding to the analysis that evaluates the occurrence epigenetic 
marking in chromosomes is homogeneous, in the marking zone and the non marking 
zone.  
 Global union for dinucleotide:  
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 Global union for trinucleotide:  
 
 
 
 Global union for tetranucleotide:  
 
 
 
